×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Biocryst Pharmaceuticals Inc.. (BCRX) NASDAQ

$5.08 (0.07) (-1.36%)

Market Cap: $1.06B

As of 03/28/24 04:00 PM EDT. Market closed.

(BCRX)

Biocryst Pharmaceuticals Inc.. (BCRX)
NASDAQ

$5.08
(0.07) (-1.36%)

Market Cap: $1.06B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in ... read more

biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Jon Stonehouse
Full Time Employees
496
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$4.17M
URL
Address
4505 Emperor Blvd Ste 200, North Carolina, Durham, 27703-8457.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Jon Stonehouse
Full Time Employees
496
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$4.17M
Address
4505 Emperor Blvd Ste 200, North Carolina, Durham, 27703-8457.
PRICE CHART FOR BIOCRYST PHARMACEUTICALS INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.24
Previous Close
$5.15
Days Range
$4.98 - $5.21
52 week range
$4.82 - $9.07
Volume
3,491,454
Avg. Volume (30 days)
3,437,196
Market Cap
$1.06B
Dividend Yield
-
P/E
(4.69)
Shares Outstanding
206,149,929
Open
$5.24
Previous Close
$5.15
Days Range
$4.98 - $5.21
52 week range
$4.82 - $9.07
Volume
3,491,454
Avg. Volume (30 days)
3,437,196
Market Cap
$1.06B
Dividend Yield
-
P/E
(4.69)
Shares Outstanding
206,149,929
FINANCIAL STATEMENTS FOR BIOCRYST PHARMACEUTICALS INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BIOCRYST PHARMACEUTICALS INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
MILANO VINCENTDirectorFeb 29, 2024 Option Exercise$5.639995,62451,997Mar 04, 2024, 05:25 PM
HEGGIE THERESADirectorFeb 29, 2024 Option Exercise$5.639995,62451,860Mar 04, 2024, 04:32 PM
Thackray Helen M.Chief R&D OfficerDec 19, 2023 Option Exercise$6.055,58033,759249,664Dec 20, 2023, 04:42 PM
Stonehouse Jon PPresident & CEODec 19, 2023 Option Exercise$6.0514,08985,2381,114,770Dec 20, 2023, 04:40 PM
Gayer Charles KChief Commercial OfficerDec 19, 2023 Option Exercise$6.052,48215,016274,533Dec 20, 2023, 04:38 PM
Doyle AnthonyChief Financial OfficerDec 19, 2023 Option Exercise$6.052,48215,016227,444Dec 20, 2023, 04:35 PM
Barnes Alane PChief Legal OfficerDec 19, 2023 Option Exercise$6.052,48215,016293,539Dec 20, 2023, 04:33 PM
Thackray Helen M.Chief R&D OfficerDec 14, 2023 Option Exercise$6.433,03119,489255,244Dec 18, 2023, 04:47 PM
Stonehouse Jon PPresident & CEODec 14, 2023 Option Exercise$6.4313,59287,3971,128,859Dec 18, 2023, 04:43 PM
Gayer Charles KChief Commercial OfficerDec 14, 2023 Option Exercise$6.435,84037,551277,015Dec 18, 2023, 04:40 PM
Doyle AnthonyChief Financial OfficerDec 14, 2023 Option Exercise$6.435,47535,204229,926Dec 18, 2023, 04:37 PM
Barnes Alane PChief Legal OfficerDec 14, 2023 Option Exercise$6.434,01525,816296,021Dec 18, 2023, 04:34 PM
MILANO VINCENTDirectorNov 30, 2023 Option Exercise$5.889565,62150,998Dec 01, 2023, 04:42 PM
HEGGIE THERESADirectorNov 30, 2023 Option Exercise$5.889565,62150,861Dec 01, 2023, 04:40 PM
MILANO VINCENTDirectorAug 31, 2023 Option Exercise$7.117915,62450,042Sep 05, 2023, 04:43 PM
HEGGIE THERESADirectorAug 31, 2023 Option Exercise$7.117915,62449,905Sep 05, 2023, 04:41 PM
SANDERS MACHELLEDirectorJun 15, 2023 Sale$7.984,00031,92025,611Jun 15, 2023, 04:37 PM
Hutson Nancy JDirectorJun 14, 2023 Sale$8.0412,866103,44381,818Jun 15, 2023, 04:33 PM
MILANO VINCENTDirectorMay 31, 2023 Option Exercise$8.276805,62432,506Jun 02, 2023, 04:36 PM
LEVIN ALAN GDirectorMay 31, 2023 Option Exercise$8.271,36011,24720,345Jun 02, 2023, 04:34 PM
HEGGIE THERESADirectorMay 31, 2023 Option Exercise$8.276805,62432,369Jun 02, 2023, 04:32 PM
Thackray Helen M.Chief R&D OfficerApr 03, 2023 Sale$8.297,00058,030207,275Apr 05, 2023, 04:33 PM
Stonehouse Jon PPresident & CEOMar 21, 2023 Option Exercise$3.2231,05599,9971,039,794Mar 23, 2023, 04:40 PM
MILANO VINCENTDirectorFeb 28, 2023 Option Exercise$8.856355,62031,826Mar 02, 2023, 04:44 PM
INGRAM ROBERT ALEXANDERDirectorFeb 28, 2023 Option Exercise$8.852,25919,992100,198Mar 02, 2023, 04:41 PM
Stonehouse Jon PPresident & CEOFeb 01, 2023 Option Exercise$5.45100,000545,0001,108,739Feb 02, 2023, 05:20 PM
Stonehouse Jon PPresident & CEOFeb 01, 2023 Sale$10.38100,0001,038,0001,008,739Feb 02, 2023, 05:20 PM
LEE KENNETH B JRDirectorJan 31, 2023 Option Exercise$1.7115,00025,65052,118Feb 02, 2023, 05:15 PM
Stonehouse Jon PPresident & CEODec 15, 2022 Sale$10.9014,100153,690887,730Dec 19, 2022, 05:09 PM
Thackray Helen M.Chief R&D OfficerDec 15, 2022 Sale$10.893,12534,031133,275Dec 19, 2022, 04:58 PM
Doyle AnthonyChief Financial OfficerDec 15, 2022 Sale$10.905,70062,130163,966Dec 19, 2022, 04:55 PM
Gayer Charles KChief Commercial OfficerDec 15, 2022 Sale$10.906,10066,490211,610Dec 19, 2022, 04:48 PM
Jones Michael LExec. Director, Finance - PAODec 15, 2022 Sale$10.904454,85010,753Dec 19, 2022, 04:45 PM
Barnes Alane PChief Legal OfficerDec 15, 2022 Sale$10.884,17545,424198,770Dec 19, 2022, 04:38 PM
Jones Michael LExec. Director, Finance - PAODec 01, 2022 Option Exercise$1.428,60012,21219,798Dec 02, 2022, 06:36 PM
Jones Michael LExec. Director, Finance - PAODec 01, 2022 Sale$13.018,600111,88611,198Dec 02, 2022, 06:36 PM
Stonehouse Jon PPresident & CEODec 01, 2022 Option Exercise$1.42214,917305,1821,116,747Dec 02, 2022, 06:33 PM
Stonehouse Jon PPresident & CEODec 02, 2022 Option Exercise$1.4282,656117,372984,486Dec 02, 2022, 06:33 PM
Stonehouse Jon PPresident & CEODec 02, 2022 Sale$12.8082,6561,057,997901,830Dec 02, 2022, 06:33 PM
Stonehouse Jon PPresident & CEODec 01, 2022 Sale$13.00214,9172,793,921901,830Dec 02, 2022, 06:33 PM
HEGGIE THERESADirectorNov 30, 2022 Option Exercise$13.364215,62531,054Dec 02, 2022, 06:30 PM
MILANO VINCENTDirectorNov 30, 2022 Option Exercise$13.364215,62531,191Dec 02, 2022, 06:28 PM
LEVIN ALAN GDirectorNov 30, 2022 Option Exercise$13.3684211,24917,714Dec 02, 2022, 06:26 PM
INGRAM ROBERT ALEXANDERDirectorNov 30, 2022 Option Exercise$13.361,49720,00097,939Dec 02, 2022, 06:24 PM
Babu Yarlagadda SChief Discovery OfficerNov 14, 2022 Option Exercise$1.42100,000142,000330,056Nov 16, 2022, 04:19 PM
Babu Yarlagadda SChief Discovery OfficerNov 14, 2022 Sale$13.8831,515437,428298,541Nov 16, 2022, 04:19 PM
MILANO VINCENTDirectorAug 31, 2022 Option Exercise$13.904045,61630,770Sep 02, 2022, 04:36 PM
LEVIN ALAN GDirectorAug 31, 2022 Option Exercise$13.9080911,24516,872Sep 02, 2022, 04:34 PM
INGRAM ROBERT ALEXANDERDirectorAug 31, 2022 Option Exercise$13.901,43819,98896,442Sep 02, 2022, 04:31 PM
HEGGIE THERESADirectorAug 31, 2022 Option Exercise$13.904045,61630,633Sep 02, 2022, 04:29 PM
ASELAGE STEVEDirectorMay 31, 2022 Option Exercise$9.315695,29733,728Jun 02, 2022, 04:43 PM
HEGGIE THERESADirectorMay 31, 2022 Option Exercise$9.311,13810,59517,363Jun 02, 2022, 04:40 PM
LEVIN ALAN GDirectorMay 31, 2022 Option Exercise$9.311,13810,5953,197Jun 02, 2022, 04:37 PM
INGRAM ROBERT ALEXANDERDirectorMay 31, 2022 Option Exercise$9.312,07819,34682,138Jun 02, 2022, 04:34 PM
ABERCROMBIE GEORGE BDirectorApr 18, 2022 Option Exercise$3.325,00016,6005,000Apr 20, 2022, 04:23 PM
ABERCROMBIE GEORGE BDirectorApr 18, 2022 Sale$11.045,00055,2000Apr 20, 2022, 04:23 PM
Thackray Helen M.Chief R&D OfficerApr 01, 2022 Sale$16.207,600123,120136,400Apr 04, 2022, 04:32 PM
Sheridan William PChief Medical OfficerMar 10, 2022 Option Exercise$3.22148,302477,532199,093Mar 14, 2022, 04:21 PM
Sheridan William PChief Medical OfficerMar 10, 2022 Sale$16.88161,1392,719,49339,354Mar 14, 2022, 04:21 PM
Babu Yarlagadda SChief Discovery OfficerMar 07, 2022 Sale$17.1620,000343,200230,056Mar 09, 2022, 04:24 PM
Jones Michael LExec. Director, Finance - PAOMar 01, 2022 Option Exercise$4.732,30010,87913,498Mar 03, 2022, 05:04 PM
Jones Michael LExec. Director, Finance - PAOMar 01, 2022 Sale$17.202,30039,56011,198Mar 03, 2022, 05:04 PM
LEVIN ALAN GDirectorFeb 28, 2022 Option Exercise$16.616029,9992,059Mar 02, 2022, 04:43 PM
INGRAM ROBERT ALEXANDERDirectorFeb 28, 2022 Option Exercise$16.611,12818,73680,060Mar 02, 2022, 04:40 PM
ABERCROMBIE GEORGE BDirectorFeb 15, 2022 Option Exercise$3.325,00016,6005,000Feb 16, 2022, 04:25 PM
ABERCROMBIE GEORGE BDirectorFeb 15, 2022 Sale$18.505,00092,5000Feb 16, 2022, 04:25 PM
Stonehouse Jon PPresident & CEOJan 11, 2022 Option Exercise$4.73184,000870,3201,085,602Jan 13, 2022, 04:45 PM
Stonehouse Jon PPresident & CEOJan 11, 2022 Sale$15.04184,0002,767,360901,602Jan 13, 2022, 04:45 PM
Babu Yarlagadda SChief Discovery OfficerDec 07, 2021 Option Exercise$4.7362,000293,260245,156Dec 09, 2021, 04:38 PM
Babu Yarlagadda SChief Discovery OfficerDec 07, 2021 Sale$12.2030,100367,220215,056Dec 09, 2021, 04:38 PM
ASELAGE STEVEDirectorNov 30, 2021 Option Exercise$12.064144,99332,858Dec 02, 2021, 04:15 PM
LEVIN ALAN GDirectorNov 30, 2021 Option Exercise$12.068299,9981,457Dec 02, 2021, 04:13 PM
HEGGIE THERESADirectorNov 30, 2021 Option Exercise$12.068299,99815,623Dec 02, 2021, 04:10 PM
INGRAM ROBERT ALEXANDERDirectorNov 30, 2021 Option Exercise$12.061,55418,74178,932Dec 02, 2021, 04:08 PM
MILANO VINCENTDirectorNov 24, 2021 Buy$12.197,50091,42517,500Nov 24, 2021, 06:35 PM
Doyle AnthonyChief Financial OfficerNov 23, 2021 Buy$12.4835,258440,02093,719Nov 24, 2021, 06:35 PM
ABERCROMBIE GEORGE BDirectorNov 15, 2021 Option Exercise$3.325,00016,6005,000Nov 17, 2021, 04:27 PM
ABERCROMBIE GEORGE BDirectorNov 15, 2021 Sale$12.275,00061,3500Nov 17, 2021, 04:27 PM
Hutson Nancy JDirectorOct 15, 2021 Option Exercise$3.46105,000363,450170,073Oct 19, 2021, 04:21 PM
Hutson Nancy JDirectorOct 15, 2021 Sale$15.40105,0001,617,00065,073Oct 19, 2021, 04:21 PM
ABERCROMBIE GEORGE BDirectorSep 15, 2021 Option Exercise$2.635,00013,1505,000Sep 17, 2021, 04:31 PM
ABERCROMBIE GEORGE BDirectorSep 15, 2021 Sale$15.065,00075,3000Sep 17, 2021, 04:31 PM
LEE KENNETH B JRDirectorSep 13, 2021 Option Exercise$3.2215,00048,30030,252Sep 15, 2021, 04:26 PM
LEE KENNETH B JRDirectorSep 13, 2021 Sale$15.356,00092,10024,252Sep 15, 2021, 04:26 PM
ABERCROMBIE GEORGE BDirectorSep 10, 2021 Option Exercise$2.8671,000202,71074,000Sep 14, 2021, 04:14 PM
ABERCROMBIE GEORGE BDirectorSep 10, 2021 Sale$15.0974,0001,116,6600Sep 14, 2021, 04:14 PM
LEVIN ALAN GDirectorAug 31, 2021 Option Exercise$15.926289,998628Sep 02, 2021, 04:36 PM
INGRAM ROBERT ALEXANDERDirectorAug 31, 2021 Option Exercise$15.921,17718,73877,378Sep 02, 2021, 04:33 PM
HEGGIE THERESADirectorAug 31, 2021 Option Exercise$15.926289,99814,794Sep 02, 2021, 04:30 PM
ASELAGE STEVEDirectorAug 31, 2021 Option Exercise$15.923144,99932,444Sep 02, 2021, 04:28 PM
ABERCROMBIE GEORGE BDirectorJul 15, 2021 Option Exercise$2.635,00013,1508,000Jul 19, 2021, 04:39 PM
ABERCROMBIE GEORGE BDirectorJul 15, 2021 Sale$15.695,00078,4503,000Jul 19, 2021, 04:39 PM
Hutson Nancy JDirectorMay 28, 2021 Option Exercise$15.773174,99965,073Jun 01, 2021, 04:24 PM
ASELAGE STEVEDirectorMay 28, 2021 Option Exercise$15.776349,99832,130Jun 01, 2021, 04:16 PM
Barnes Alane PChief Legal OfficerMay 11, 2021 Option Exercise$4.14102,780425,442213,055May 13, 2021, 04:43 PM
Barnes Alane PChief Legal OfficerMay 12, 2021 Option Exercise$4.7335,852169,580146,127May 13, 2021, 04:43 PM
Barnes Alane PChief Legal OfficerMay 11, 2021 Sale$12.04102,7801,237,471110,275May 13, 2021, 04:43 PM
ABERCROMBIE GEORGE BDirectorMay 10, 2021 Sale$12.707,00088,9003,000May 12, 2021, 05:02 PM
Jones Michael LExec. Director, Finance - PAOMar 18, 2021 Option Exercise$3.514,50015,7955,348Mar 22, 2021, 04:19 PM
INGRAM ROBERT ALEXANDERDirectorFeb 26, 2021 Option Exercise$10.781,73918,74675,013Mar 02, 2021, 04:55 PM
Hutson Nancy JDirectorFeb 26, 2021 Option Exercise$10.784634,99164,756Mar 02, 2021, 04:53 PM
HEGGIE THERESADirectorFeb 26, 2021 Option Exercise$10.784634,99113,849Mar 02, 2021, 04:50 PM
ASELAGE STEVEDirectorFeb 26, 2021 Option Exercise$10.789279,99331,496Mar 02, 2021, 04:47 PM
Sheridan William PSenior VP - CMOFeb 22, 2021 Option Exercise$4.1541,250171,18852,725Feb 24, 2021, 04:34 PM
Sheridan William PSenior VP - CMOFeb 22, 2021 Sale$11.5741,250477,26211,475Feb 24, 2021, 04:34 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryFeb 19, 2021 Option Exercise$11.5322,431258,629183,156Feb 23, 2021, 04:25 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryFeb 19, 2021 Option Exercise$4.1550,000207,500205,587Feb 23, 2021, 04:25 PM
Stonehouse Jon PPresident & CEODec 15, 2020 Option Exercise$4.15134,278557,254918,364Dec 17, 2020, 04:20 PM
Stonehouse Jon PPresident & CEODec 15, 2020 Sale$8.32134,2781,117,193784,086Dec 17, 2020, 04:20 PM
Barnes Alane PSenior VP, Chief Legal OfficerDec 11, 2020 Option Exercise$4.1513,74157,025121,802Dec 15, 2020, 05:35 PM
Barnes Alane PSenior VP, Chief Legal OfficerDec 11, 2020 Sale$7.9613,741109,378108,061Dec 15, 2020, 05:35 PM
Barnes Alane PSenior VP, Chief Legal OfficerDec 04, 2020 Option Exercise$4.1513,74157,025121,802Dec 08, 2020, 04:12 PM
Barnes Alane PSenior VP, Chief Legal OfficerDec 04, 2020 Sale$6.2313,74185,606108,061Dec 08, 2020, 04:12 PM
HEGGIE THERESADirectorNov 30, 2020 Option Exercise$5.119784,99813,386Dec 02, 2020, 04:21 PM
ASELAGE STEVEDirectorNov 30, 2020 Option Exercise$5.111,9569,99530,569Dec 02, 2020, 04:19 PM
Hutson Nancy JDirectorNov 30, 2020 Option Exercise$5.119784,99864,293Dec 02, 2020, 04:16 PM
INGRAM ROBERT ALEXANDERDirectorNov 30, 2020 Option Exercise$5.113,66918,74973,274Dec 02, 2020, 04:14 PM
Hutson Nancy JDirectorAug 31, 2020 Option Exercise$4.151,2044,99763,315Sep 02, 2020, 04:44 PM
HEGGIE THERESADirectorAug 31, 2020 Option Exercise$4.151,2044,99712,408Sep 02, 2020, 04:39 PM
ASELAGE STEVEDirectorAug 31, 2020 Option Exercise$4.152,4099,99728,613Sep 02, 2020, 04:36 PM
INGRAM ROBERT ALEXANDERDirectorAug 31, 2020 Option Exercise$4.154,51818,75069,605Sep 02, 2020, 04:33 PM
Doyle AnthonyChief Financial OfficerAug 11, 2020 Buy$4.0854,000220,32054,000Aug 12, 2020, 04:31 PM
ASELAGE STEVEDirectorJun 01, 2020 Option Exercise$4.491,1124,99826,204Jun 03, 2020, 04:24 PM
HEGGIE THERESADirectorJun 01, 2020 Option Exercise$4.491,1124,99811,204Jun 03, 2020, 04:22 PM
Hutson Nancy JDirectorJun 01, 2020 Option Exercise$4.492,2249,99762,111Jun 03, 2020, 04:20 PM
INGRAM ROBERT ALEXANDERDirectorJun 01, 2020 Option Exercise$4.494,17118,74965,087Jun 03, 2020, 04:16 PM
Hutson Nancy JDirectorMar 01, 2020 Option Exercise$3.003,3339,99959,887Mar 03, 2020, 04:50 PM
INGRAM ROBERT ALEXANDERDirectorMar 01, 2020 Option Exercise$3.006,25018,75060,916Mar 03, 2020, 04:47 PM
HEGGIE THERESADirectorMar 01, 2020 Option Exercise$3.001,6664,99810,092Mar 03, 2020, 12:00 AM
ASELAGE STEVEDirectorMar 01, 2020 Option Exercise$3.001,6664,99825,092Mar 03, 2020, 12:00 AM
HEGGIE THERESADirectorDec 01, 2019 Option Exercise$2.851,7544,9998,426Dec 03, 2019, 05:17 PM
ASELAGE STEVEDirectorDec 01, 2019 Option Exercise$2.851,7544,99923,426Dec 03, 2019, 05:14 PM
Hutson Nancy JDirectorDec 01, 2019 Option Exercise$2.853,5089,99856,554Dec 03, 2019, 05:12 PM
INGRAM ROBERT ALEXANDERDirectorDec 01, 2019 Option Exercise$2.856,57818,74754,666Dec 03, 2019, 05:09 PM
Stonehouse Jon PPresident & CEONov 18, 2019 Buy$1.4550,00072,500778,086Nov 18, 2019, 04:17 PM
Sniecinski MeganChief Business OfficerNov 18, 2019 Buy$1.4545,00065,25045,000Nov 18, 2019, 04:16 PM
LEE KENNETH B JRDirectorNov 18, 2019 Buy$1.455,0007,25015,252Nov 18, 2019, 04:14 PM
INGRAM ROBERT ALEXANDERDirectorNov 18, 2019 Buy$1.4520,00029,00048,088Nov 18, 2019, 04:12 PM
Hutson Nancy JDirectorNov 18, 2019 Buy$1.4510,00014,50053,046Nov 18, 2019, 04:10 PM
HEGGIE THERESADirectorNov 18, 2019 Buy$1.455,0007,2506,672Nov 18, 2019, 04:08 PM
Barnes Alane PSenior VP, Chief Legal OfficerNov 18, 2019 Buy$1.4520,00029,000102,061Nov 18, 2019, 04:05 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryNov 18, 2019 Buy$1.4525,00036,250155,587Nov 18, 2019, 04:03 PM
ASELAGE STEVEDirectorNov 18, 2019 Buy$1.4515,00021,75021,672Nov 18, 2019, 04:01 PM
HEGGIE THERESADirectorSep 01, 2019 Option Exercise$2.991,6724,9991,672Sep 04, 2019, 04:16 PM
ASELAGE STEVEDirectorSep 01, 2019 Option Exercise$2.991,6724,9996,672Sep 04, 2019, 04:14 PM
Hutson Nancy JDirectorSep 01, 2019 Option Exercise$2.993,3449,99943,046Sep 04, 2019, 04:12 PM
INGRAM ROBERT ALEXANDERDirectorSep 01, 2019 Option Exercise$2.996,27018,74728,088Sep 04, 2019, 04:08 PM
ASELAGE STEVEDirectorMay 22, 2019 Buy$3.573,00010,7105,000May 24, 2019, 04:20 PM
STAAB THOMAS R IISenior Vice President and CFOMay 16, 2019 Option Exercise$1.424,7506,745134,926May 20, 2019, 04:21 PM
STAAB THOMAS R IISenior Vice President and CFOMay 17, 2019 Sale$7.452,50018,625125,176May 20, 2019, 04:21 PM
STAAB THOMAS R IISenior Vice President and CFOMay 16, 2019 Sale$7.727,25055,970127,676May 20, 2019, 04:21 PM
STAAB THOMAS R IISenior Vice President and CFOMay 15, 2019 Option Exercise$1.424,7506,745137,426May 16, 2019, 04:29 PM
STAAB THOMAS R IISenior Vice President and CFOMay 14, 2019 Option Exercise$1.424,5006,390137,176May 16, 2019, 04:29 PM
STAAB THOMAS R IISenior Vice President and CFOMay 15, 2019 Sale$7.927,25057,420130,176May 16, 2019, 04:29 PM
STAAB THOMAS R IISenior Vice President and CFOMay 14, 2019 Sale$7.624,50034,290132,676May 16, 2019, 04:29 PM
STAAB THOMAS R IISenior Vice President and CFOMay 13, 2019 Option Exercise$5.519,75053,723142,426May 13, 2019, 04:57 PM
STAAB THOMAS R IISenior Vice President and CFOMay 09, 2019 Option Exercise$5.519,75053,723142,426May 13, 2019, 04:57 PM
STAAB THOMAS R IISenior Vice President and CFOMay 13, 2019 Sale$7.769,75075,660132,676May 13, 2019, 04:57 PM
STAAB THOMAS R IISenior Vice President and CFOMay 09, 2019 Sale$7.639,75074,393132,676May 13, 2019, 04:57 PM
STAAB THOMAS R IISenior Vice President and CFOMay 02, 2019 Option Exercise$5.517,75042,703140,426May 06, 2019, 04:51 PM
STAAB THOMAS R IISenior Vice President and CFOMay 06, 2019 Option Exercise$5.519,00049,590141,676May 06, 2019, 04:51 PM
STAAB THOMAS R IISenior Vice President and CFOMay 06, 2019 Sale$7.759,00069,750132,676May 06, 2019, 04:51 PM
STAAB THOMAS R IISenior Vice President and CFOMay 02, 2019 Sale$7.307,75056,575132,676May 06, 2019, 04:51 PM
STAAB THOMAS R IISenior Vice President and CFOApr 04, 2019 Option Exercise$5.517,50041,325140,176Apr 08, 2019, 02:30 PM
STAAB THOMAS R IISenior Vice President and CFOApr 04, 2019 Sale$8.817,50066,075132,676Apr 08, 2019, 02:30 PM
ASELAGE STEVEDirectorMar 12, 2019 Buy$8.302,00016,6002,000Mar 14, 2019, 04:18 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryJan 31, 2019 Option Exercise$8.689,38781,479130,587Feb 04, 2019, 04:13 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryJan 31, 2019 Option Exercise$1.2031,87438,249132,272Feb 04, 2019, 04:13 PM
STAAB THOMAS R IISenior Vice President and CFOJan 28, 2019 Option Exercise$5.455,00027,250133,426Jan 30, 2019, 04:10 PM
STAAB THOMAS R IISenior Vice President and CFOJan 28, 2019 Sale$9.855,00049,250128,426Jan 30, 2019, 04:10 PM
Powell LynneSenior VP - CCOJan 28, 2019 Option Exercise$3.226,00019,3204,000Jan 29, 2019, 04:21 PM
Powell LynneSenior VP - CCOJan 25, 2019 Option Exercise$3.226,00019,3206,000Jan 29, 2019, 04:21 PM
Powell LynneSenior VP - CCOJan 28, 2019 Sale$9.896,00059,3400Jan 29, 2019, 04:21 PM
Powell LynneSenior VP - CCOJan 25, 2019 Sale$9.606,00057,6000Jan 29, 2019, 04:21 PM
Powell LynneSenior VP - CCOJan 18, 2019 Option Exercise$3.222,0006,4402,000Jan 23, 2019, 04:12 PM
Powell LynneSenior VP - CCOJan 18, 2019 Sale$9.402,00018,8000Jan 23, 2019, 04:12 PM
Powell LynneSenior VP - CCOJan 16, 2019 Option Exercise$3.223,0469,8083,046Jan 18, 2019, 04:03 PM
Powell LynneSenior VP - CCOJan 16, 2019 Sale$9.273,04628,2360Jan 18, 2019, 04:03 PM
Powell LynneSenior VP - CCOJan 14, 2019 Option Exercise$3.229543,072954Jan 16, 2019, 04:24 PM
Powell LynneSenior VP - CCOJan 14, 2019 Sale$9.209548,7770Jan 16, 2019, 04:24 PM
STAAB THOMAS R IISenior Vice President and CFOJan 01, 2019 Option Exercise$8.077856,335132,676Jan 03, 2019, 04:30 PM
Barnes Alane PSenior VP, Chief Legal OfficerJan 01, 2019 Option Exercise$8.074233,41477,530Jan 03, 2019, 12:00 AM
Sheridan William PSenior VP - CMOJan 01, 2019 Option Exercise$8.071,0878,7721,638Jan 03, 2019, 12:00 AM
Stonehouse Jon PPresident & CEOJan 01, 2019 Option Exercise$8.073,56828,794724,106Jan 03, 2019, 12:00 AM
Babu Yarlagadda SSenior VP - Drug DiscoveryJan 01, 2019 Option Exercise$8.077716,222108,100Jan 03, 2019, 12:00 AM
Sheridan William PSenior VP - CMODec 18, 2018 Sale$7.5820,488155,2992,725Dec 20, 2018, 04:37 PM
Powell LynneSenior VP - CCODec 10, 2018 Option Exercise$3.224,00012,8802,000Dec 12, 2018, 04:13 PM
Powell LynneSenior VP - CCODec 10, 2018 Sale$9.064,00036,2400Dec 12, 2018, 04:13 PM
Stonehouse Jon PPresident & CEODec 03, 2018 Option Exercise$1.2080,00096,000807,674Dec 06, 2018, 04:34 PM
Stonehouse Jon PPresident & CEODec 03, 2018 Sale$9.1280,000729,600727,674Dec 06, 2018, 04:34 PM
STAAB THOMAS R IISenior Vice President and CFODec 04, 2018 Sale$9.453,92237,063133,461Dec 06, 2018, 04:30 PM
Barnes Alane PSenior VP, Chief Legal OfficerNov 30, 2018 Option Exercise$1.4225,00035,500122,243Dec 04, 2018, 04:11 PM
Barnes Alane PSenior VP, Chief Legal OfficerNov 30, 2018 Sale$9.0744,290401,71077,953Dec 04, 2018, 04:11 PM
Erck Stanley CDirectorNov 28, 2018 Option Exercise$1.498,33312,41648,333Nov 30, 2018, 04:02 PM
Powell LynneSenior VP - CCONov 21, 2018 Option Exercise$3.2212,00038,64014,455Nov 26, 2018, 04:22 PM
Powell LynneSenior VP - CCONov 21, 2018 Sale$9.0514,455130,8402,455Nov 26, 2018, 04:22 PM
STAAB THOMAS R IISenior Vice President and CFONov 23, 2018 Option Exercise$3.783,50013,230140,883Nov 26, 2018, 04:19 PM
STAAB THOMAS R IISenior Vice President and CFONov 21, 2018 Option Exercise$4.4812,00053,710144,383Nov 26, 2018, 04:19 PM
STAAB THOMAS R IISenior Vice President and CFONov 23, 2018 Sale$9.663,50033,810137,383Nov 26, 2018, 04:19 PM
STAAB THOMAS R IISenior Vice President and CFONov 21, 2018 Sale$9.2212,000110,610137,383Nov 26, 2018, 04:19 PM
Powell LynneSenior VP - CCONov 20, 2018 Option Exercise$3.229,12729,38917,732Nov 21, 2018, 04:51 PM
Powell LynneSenior VP - CCONov 19, 2018 Option Exercise$3.221936218,798Nov 21, 2018, 04:51 PM
Powell LynneSenior VP - CCONov 20, 2018 Sale$8.5615,277130,7148,605Nov 21, 2018, 04:51 PM
Powell LynneSenior VP - CCONov 19, 2018 Sale$8.301931,6028,605Nov 21, 2018, 04:51 PM
STAAB THOMAS R IISenior Vice President and CFONov 19, 2018 Option Exercise$3.7875283137,458Nov 21, 2018, 04:48 PM
STAAB THOMAS R IISenior Vice President and CFONov 20, 2018 Option Exercise$3.4511,12338,405143,883Nov 21, 2018, 04:48 PM
STAAB THOMAS R IISenior Vice President and CFONov 20, 2018 Sale$8.6811,12396,494137,383Nov 21, 2018, 04:48 PM
STAAB THOMAS R IISenior Vice President and CFONov 19, 2018 Sale$8.3075623137,383Nov 21, 2018, 04:48 PM
STAAB THOMAS R IISenior Vice President and CFONov 08, 2018 Option Exercise$3.3213,41544,485148,496Nov 09, 2018, 04:14 PM
STAAB THOMAS R IISenior Vice President and CFONov 07, 2018 Option Exercise$3.226722,164138,055Nov 09, 2018, 04:14 PM
STAAB THOMAS R IISenior Vice President and CFONov 08, 2018 Sale$8.1313,415109,011137,383Nov 09, 2018, 04:14 PM
STAAB THOMAS R IISenior Vice President and CFONov 07, 2018 Sale$8.006725,376137,383Nov 09, 2018, 04:14 PM
Powell LynneSenior VP - CCONov 08, 2018 Option Exercise$3.225,28017,00213,885Nov 09, 2018, 04:11 PM
Powell LynneSenior VP - CCONov 07, 2018 Option Exercise$3.223009668,905Nov 09, 2018, 04:11 PM
Powell LynneSenior VP - CCONov 07, 2018 Sale$8.003002,4008,605Nov 09, 2018, 04:11 PM
Powell LynneSenior VP - CCONov 08, 2018 Sale$8.155,28043,0328,605Nov 09, 2018, 04:11 PM
Powell LynneSenior VP - CCONov 05, 2018 Option Exercise$3.221003228,705Nov 07, 2018, 04:05 PM
Powell LynneSenior VP - CCONov 05, 2018 Sale$8.001008008,605Nov 07, 2018, 04:05 PM
STAAB THOMAS R IISenior Vice President and CFONov 05, 2018 Option Exercise$3.22215692137,598Nov 07, 2018, 04:03 PM
STAAB THOMAS R IISenior Vice President and CFONov 05, 2018 Sale$8.002151,720137,383Nov 07, 2018, 04:03 PM
Powell LynneSenior VP - CCONov 02, 2018 Option Exercise$3.221,0003,2209,605Nov 06, 2018, 04:07 PM
Powell LynneSenior VP - CCONov 02, 2018 Sale$8.001,0008,0008,605Nov 06, 2018, 04:07 PM
STAAB THOMAS R IISenior Vice President and CFONov 02, 2018 Option Exercise$3.4010,85636,916144,739Nov 06, 2018, 04:04 PM
STAAB THOMAS R IISenior Vice President and CFONov 02, 2018 Sale$7.8410,85685,090137,383Nov 06, 2018, 04:04 PM
Powell LynneSenior VP - CCONov 01, 2018 Sale$7.511,54411,5958,605Nov 05, 2018, 01:17 PM
STAAB THOMAS R IISenior Vice President and CFOOct 19, 2018 Option Exercise$3.783,15011,907140,533Oct 23, 2018, 01:34 PM
STAAB THOMAS R IISenior Vice President and CFOOct 19, 2018 Sale$7.453,15023,467137,383Oct 23, 2018, 01:34 PM
Powell LynneSenior VP - CCOOct 19, 2018 Sale$7.5010075010,149Oct 23, 2018, 01:31 PM
STAAB THOMAS R IISenior Vice President and CFOOct 03, 2018 Option Exercise$3.271,0723,508138,355Oct 04, 2018, 01:09 PM
STAAB THOMAS R IISenior Vice President and CFOOct 02, 2018 Option Exercise$3.438,77830,085142,911Oct 04, 2018, 01:09 PM
STAAB THOMAS R IISenior Vice President and CFOOct 03, 2018 Sale$7.281,0727,802137,383Oct 04, 2018, 01:09 PM
STAAB THOMAS R IISenior Vice President and CFOOct 02, 2018 Sale$7.248,77863,556137,383Oct 04, 2018, 01:09 PM
Sheridan William PSenior VP - CMOAug 09, 2018 Option Exercise$1.4262,50088,75085,713Aug 13, 2018, 10:07 AM
Sheridan William PSenior VP - CMOAug 09, 2018 Sale$7.0362,500439,37523,213Aug 13, 2018, 10:07 AM
Sheridan William PSenior VP - CMOJun 01, 2018 Option Exercise$2.5842,112108,64963,170Jun 05, 2018, 03:07 PM
Sheridan William PSenior VP - CMOJun 01, 2018 Sale$6.3042,112265,30621,058Jun 05, 2018, 03:07 PM
INGRAM ROBERT ALEXANDERDirectorJun 01, 2018 Option Exercise$6.432,91618,75021,818Jun 04, 2018, 02:54 PM
Hutson Nancy JDirectorJun 01, 2018 Option Exercise$6.431,5559,99939,702Jun 04, 2018, 02:48 PM
Stonehouse Jon PPresident & CEOMay 17, 2018 Option Exercise$1.4270,427100,006725,519May 21, 2018, 09:31 AM
Barnes Alane PVP, General Counsel & Corp SecMay 15, 2018 Option Exercise$5.913,00417,75495,264May 17, 2018, 09:25 AM
Barnes Alane PVP, General Counsel & Corp SecMay 15, 2018 Option Exercise$1.4212,50017,75098,268May 17, 2018, 09:25 AM
Babu Yarlagadda SSenior VP - Drug DiscoveryMar 06, 2018 Option Exercise$5.1821,125109,427108,871Mar 08, 2018, 03:48 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryMar 06, 2018 Option Exercise$3.2630,00097,800120,618Mar 08, 2018, 03:48 PM
Stonehouse Jon PPresident & CEOFeb 28, 2018 Option Exercise$4.9743,224214,823655,092Mar 02, 2018, 02:23 PM
Stonehouse Jon PPresident & CEOFeb 28, 2018 Option Exercise$3.2656,949185,654698,316Mar 02, 2018, 02:23 PM
Barnes Alane PVP, General Counsel & Corp SecFeb 28, 2018 Option Exercise$3.266,70921,87185,768Mar 02, 2018, 02:21 PM
INGRAM ROBERT ALEXANDERDirectorMar 01, 2018 Option Exercise$4.973,77218,74718,902Mar 02, 2018, 02:14 PM
Hutson Nancy JDirectorMar 01, 2018 Option Exercise$4.972,01210,00038,147Mar 02, 2018, 02:11 PM
Barnes Alane PVP, General Counsel & Corp SecJan 20, 2018 Option Exercise$5.591,96110,96277,129Jan 23, 2018, 09:12 AM
Babu Yarlagadda SSenior VP - Drug DiscoveryJan 20, 2018 Option Exercise$5.593,87221,64499,996Jan 23, 2018, 09:10 AM
Sheridan William PSenior VP - CMOJan 20, 2018 Option Exercise$5.594,62825,87118,058Jan 23, 2018, 09:08 AM
STAAB THOMAS R IISenior Vice President and CFOJan 20, 2018 Option Exercise$5.593,97922,243137,383Jan 23, 2018, 09:06 AM
Stonehouse Jon PPresident & CEOJan 20, 2018 Option Exercise$5.599,58453,575638,367Jan 23, 2018, 09:03 AM
Barnes Alane PVP, General Counsel & Corp SecJan 01, 2018 Option Exercise$4.914592,25479,090Jan 03, 2018, 09:13 AM
Babu Yarlagadda SSenior VP - Drug DiscoveryJan 01, 2018 Option Exercise$4.918384,115103,868Jan 03, 2018, 09:11 AM
Sheridan William PSenior VP - CMOJan 01, 2018 Option Exercise$4.911,1695,74022,686Jan 03, 2018, 09:04 AM
STAAB THOMAS R IISenior Vice President and CFOJan 01, 2018 Option Exercise$4.918524,183141,362Jan 03, 2018, 09:02 AM
Stonehouse Jon PPresident & CEOJan 01, 2018 Option Exercise$4.912,71613,336647,951Jan 03, 2018, 08:59 AM
INGRAM ROBERT ALEXANDERDirectorDec 01, 2017 Option Exercise$5.083,69018,74515,130Dec 04, 2017, 03:53 PM
Hutson Nancy JDirectorDec 01, 2017 Option Exercise$5.081,9689,99736,135Dec 04, 2017, 03:50 PM
Sheridan William PSenior VP - CMONov 13, 2017 Sale$4.7264,310303,54323,855Nov 15, 2017, 04:09 PM
Cohen Fred EDirectorSep 18, 2017 Option Exercise$4.2754,250231,647173,660Sep 20, 2017, 10:07 AM
Cohen Fred EDirectorSep 18, 2017 Sale$5.4254,250294,035119,410Sep 20, 2017, 10:07 AM
INGRAM ROBERT ALEXANDERDirectorSep 01, 2017 Option Exercise$5.103,67618,74811,440Sep 05, 2017, 11:29 AM
Hutson Nancy JDirectorSep 01, 2017 Option Exercise$5.101,9609,99634,167Sep 05, 2017, 11:27 AM
INGRAM ROBERT ALEXANDERDirectorJun 01, 2017 Option Exercise$5.151,9419,9967,764Jun 02, 2017, 04:04 PM
Hutson Nancy JDirectorJun 01, 2017 Option Exercise$5.151,9419,99632,207Jun 02, 2017, 04:01 PM
Cohen Fred EDirectorJun 01, 2017 Option Exercise$5.151,9419,996119,410Jun 02, 2017, 03:59 PM
STAAB THOMAS R IISenior Vice President and CFOMay 22, 2017 Option Exercise$5.246,99636,659142,214May 24, 2017, 04:33 PM
STAAB THOMAS R IISenior Vice President and CFOMay 22, 2017 Option Exercise$4.737,75036,658149,210May 24, 2017, 04:33 PM
STAAB THOMAS R IISenior Vice President and CFOMar 20, 2017 Option Exercise$3.783,25012,285144,710Mar 22, 2017, 10:40 AM
STAAB THOMAS R IISenior Vice President and CFOMar 20, 2017 Sale$9.203,25029,900141,460Mar 22, 2017, 10:40 AM
STAAB THOMAS R IISenior Vice President and CFOMar 16, 2017 Option Exercise$8.8012,308108,310141,460Mar 20, 2017, 03:01 PM
STAAB THOMAS R IISenior Vice President and CFOMar 16, 2017 Option Exercise$2.9736,455108,300153,768Mar 20, 2017, 03:01 PM
STAAB THOMAS R IISenior Vice President and CFOMar 10, 2017 Option Exercise$3.783,25012,285120,563Mar 14, 2017, 01:47 PM
STAAB THOMAS R IISenior Vice President and CFOMar 10, 2017 Sale$9.063,25029,445117,313Mar 14, 2017, 01:47 PM
STAAB THOMAS R IISenior Vice President and CFOMar 08, 2017 Option Exercise$3.786,50024,570123,813Mar 10, 2017, 04:19 PM
STAAB THOMAS R IISenior Vice President and CFOMar 08, 2017 Sale$8.426,50054,762120,563Mar 10, 2017, 04:19 PM
STAAB THOMAS R IISenior Vice President and CFOMar 06, 2017 Option Exercise$3.783,25012,285120,563Mar 08, 2017, 08:05 AM
STAAB THOMAS R IISenior Vice President and CFOMar 06, 2017 Sale$7.903,25025,675117,313Mar 08, 2017, 08:05 AM
INGRAM ROBERT ALEXANDERDirectorMar 02, 2017 Option Exercise$6.241,6029,9965,823Mar 02, 2017, 03:07 PM
Hutson Nancy JDirectorMar 01, 2017 Option Exercise$6.241,6029,99630,266Mar 02, 2017, 03:05 PM
Cohen Fred EDirectorMar 01, 2017 Option Exercise$6.241,6029,996117,469Mar 02, 2017, 03:03 PM
Barnes Alane PVP, General Counsel & Corp SecJan 20, 2017 Option Exercise$5.952,59915,46475,497Jan 24, 2017, 09:28 AM
Babu Yarlagadda SSenior VP - Drug DiscoveryJan 20, 2017 Option Exercise$5.955,08330,244104,706Jan 24, 2017, 09:25 AM
Sheridan William PSenior VP - CMOJan 20, 2017 Option Exercise$5.955,76134,27882,916Jan 24, 2017, 09:22 AM
STAAB THOMAS R IISenior Vice President and CFOJan 20, 2017 Option Exercise$5.955,19830,928117,313Jan 24, 2017, 09:20 AM
Stonehouse Jon PPresident & CEOJan 20, 2017 Option Exercise$5.9510,57262,903645,418Jan 24, 2017, 09:17 AM
Barnes Alane PVP, General Counsel & Corp SecJan 01, 2017 Option Exercise$6.331,2818,10978,096Jan 03, 2017, 02:13 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryJan 01, 2017 Option Exercise$6.331,63910,375109,789Jan 03, 2017, 02:09 PM
Sheridan William PSenior VP - CMOJan 01, 2017 Option Exercise$6.332,08113,17388,677Jan 03, 2017, 02:06 PM
STAAB THOMAS R IISenior Vice President and CFOJan 01, 2017 Option Exercise$6.331,67610,609122,511Jan 03, 2017, 02:03 PM
Stonehouse Jon PPresident & CEOJan 01, 2017 Option Exercise$6.338,59554,406655,990Jan 03, 2017, 01:59 PM
STAAB THOMAS R IISenior Vice President and CFODec 19, 2016 Option Exercise$3.783,25012,285127,437Dec 21, 2016, 10:42 AM
STAAB THOMAS R IISenior Vice President and CFODec 19, 2016 Sale$7.453,25024,212124,187Dec 21, 2016, 10:42 AM
INGRAM ROBERT ALEXANDERDirectorDec 01, 2016 Option Exercise$5.591,7889,9954,221Dec 02, 2016, 02:09 PM
Hutson Nancy JDirectorDec 01, 2016 Option Exercise$5.591,7889,99528,664Dec 02, 2016, 02:06 PM
Cohen Fred EDirectorDec 01, 2016 Option Exercise$5.591,7889,995115,867Dec 02, 2016, 02:03 PM
Barnes Alane PVP, General Counsel & Corp SecSep 14, 2016 Sale$4.278,35735,68479,377Sep 16, 2016, 10:54 AM
INGRAM ROBERT ALEXANDERDirectorSep 01, 2016 Option Exercise$4.112,43310,0002,433Sep 06, 2016, 03:27 PM
Hutson Nancy JDirectorSep 01, 2016 Option Exercise$4.112,43310,00026,876Sep 06, 2016, 03:25 PM
Cohen Fred EDirectorSep 01, 2016 Option Exercise$4.112,43310,000114,079Sep 06, 2016, 03:24 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryAug 25, 2016 Sale$4.0630,000121,800111,428Aug 29, 2016, 10:46 AM
BAKER BROS. ADVISORS LP10% OwnerAug 15, 2016 Sale$4.83400,0001,931,0409,419,240Aug 16, 2016, 06:11 PM
BAKER BROS. ADVISORS LP10% OwnerAug 12, 2016 Sale$5.023,645,60018,315,81710,059,679Aug 16, 2016, 06:11 PM
BAKER BROS. ADVISORS LP10% OwnerAug 16, 2016 Sale$4.299904,2469,418,390Aug 16, 2016, 06:11 PM
STAAB THOMAS R IISenior Vice President and CFOAug 12, 2016 Sale$5.224,55823,793124,187Aug 15, 2016, 02:07 PM
STAAB THOMAS R IISenior Vice President and CFOAug 11, 2016 Sale$5.051,3066,595128,745Aug 15, 2016, 02:07 PM
STAAB THOMAS R IISenior Vice President and CFOAug 09, 2016 Sale$4.4314,57764,576130,051Aug 11, 2016, 01:53 PM
Hutson Nancy JDirectorMay 31, 2016 Option Exercise$3.392,5818,75024,443Jun 02, 2016, 09:45 AM
Cohen Fred EDirectorMay 31, 2016 Option Exercise$3.392,5818,750111,646Jun 02, 2016, 09:42 AM
Barnes Alane PVP, General Counsel & Corp SecMar 01, 2016 Option Exercise$2.136871,46385,416Mar 03, 2016, 09:56 AM
Babu Yarlagadda SSenior VP - Drug DiscoveryMar 01, 2016 Option Exercise$2.139061,930141,428Mar 03, 2016, 09:47 AM
Sheridan William PSenior VP - CMOMar 01, 2016 Option Exercise$2.137991,70290,052Mar 03, 2016, 09:45 AM
STAAB THOMAS R IISenior Vice President and CFOMar 01, 2016 Option Exercise$2.13465990144,628Mar 03, 2016, 09:43 AM
Stonehouse Jon PPresident & CEOMar 01, 2016 Option Exercise$2.132,7615,881664,585Mar 03, 2016, 09:41 AM
SANDERS CHARLES ADirectorFeb 29, 2016 Option Exercise$1.994,3968,74812,971Mar 01, 2016, 04:08 PM
Hutson Nancy JDirectorFeb 29, 2016 Option Exercise$1.994,3968,74821,862Mar 01, 2016, 04:05 PM
Cohen Fred EDirectorFeb 29, 2016 Option Exercise$1.994,3968,748109,065Mar 01, 2016, 04:03 PM
BAKER BROS. ADVISORS LP10% OwnerFeb 05, 2016 Buy$6.3345,000284,65612,894,240Feb 09, 2016, 05:24 PM
BAKER BROS. ADVISORS LP10% OwnerFeb 04, 2016 Buy$6.6524,800164,91512,849,240Feb 04, 2016, 05:15 PM
BAKER BROS. ADVISORS LP10% OwnerFeb 03, 2016 Buy$6.2991,187573,31112,824,440Feb 04, 2016, 05:15 PM
BAKER BROS. ADVISORS LP10% OwnerFeb 02, 2016 Buy$6.5291,728598,36012,733,253Feb 04, 2016, 05:15 PM
Barnes Alane PVP, General Counsel & Corp SecJan 29, 2016 Option Exercise$1.4219,36827,50385,057Feb 01, 2016, 02:34 PM
BAKER BROS. ADVISORS LP10% OwnerJan 28, 2016 Buy$6.8825,000172,01512,641,525Jan 29, 2016, 04:42 PM
BAKER BROS. ADVISORS LP10% OwnerJan 27, 2016 Buy$6.9863,345441,97112,616,525Jan 29, 2016, 04:42 PM
Powell LynneSenior VP - CCOJan 26, 2016 Option Exercise$7.293,85028,0668,605Jan 27, 2016, 01:41 PM
BAKER BROS. ADVISORS LP10% OwnerJan 22, 2016 Buy$7.003,20022,38912,553,180Jan 25, 2016, 06:10 PM
BAKER BROS. ADVISORS LP10% OwnerJan 21, 2016 Buy$7.29103,600755,36812,549,980Jan 25, 2016, 06:10 PM
Barnes Alane PVP, General Counsel & Corp SecJan 20, 2016 Option Exercise$7.552,59919,62265,689Jan 22, 2016, 09:27 AM
Babu Yarlagadda SSenior VP - Drug DiscoveryJan 20, 2016 Option Exercise$7.554,72435,666142,334Jan 22, 2016, 09:24 AM
Sheridan William PSenior VP - CMOJan 20, 2016 Option Exercise$7.555,35940,46088,967Jan 22, 2016, 09:21 AM
STAAB THOMAS R IISenior Vice President and CFOJan 20, 2016 Option Exercise$7.554,82336,414145,093Jan 22, 2016, 09:18 AM
Stonehouse Jon PPresident & CEOJan 20, 2016 Option Exercise$7.5510,62480,211665,702Jan 22, 2016, 09:16 AM
Stonehouse Jon PPresident & CEOJan 20, 2016 Option Exercise$4.1524,09699,998676,326Jan 21, 2016, 01:12 PM
STAAB THOMAS R IISenior Vice President and CFOJan 19, 2016 Option Exercise$1.8115,00027,200149,916Jan 21, 2016, 11:04 AM
BAKER BROS. ADVISORS LP10% OwnerJan 20, 2016 Buy$6.8752,695362,17112,446,380Jan 20, 2016, 07:13 PM
BAKER BROS. ADVISORS LP10% OwnerJan 19, 2016 Buy$7.1292,200656,75012,393,685Jan 20, 2016, 07:13 PM
BAKER BROS. ADVISORS LP10% OwnerJan 15, 2016 Buy$7.46200,0001,491,22212,301,485Jan 20, 2016, 07:13 PM
Barnes Alane PVP, General Counsel & Corp SecJan 01, 2016 Option Exercise$10.321,28113,22068,288Jan 05, 2016, 01:31 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryJan 01, 2016 Option Exercise$10.321,63916,914147,058Jan 05, 2016, 01:29 PM
Sheridan William PSenior VP - CMOJan 01, 2016 Option Exercise$10.322,08121,47694,326Jan 05, 2016, 01:27 PM
STAAB THOMAS R IISenior Vice President and CFOJan 01, 2016 Option Exercise$10.321,67617,296134,916Jan 05, 2016, 01:25 PM
Stonehouse Jon PPresident & CEOJan 01, 2016 Option Exercise$10.328,09183,499652,230Jan 05, 2016, 01:23 PM
STAAB THOMAS R IISenior Vice President and CFODec 21, 2015 Sale$10.863,05233,145136,592Dec 22, 2015, 03:45 PM
STAAB THOMAS R IISenior Vice President and CFODec 17, 2015 Sale$10.493,00031,470139,644Dec 18, 2015, 02:54 PM
SANDERS CHARLES ADirectorNov 30, 2015 Option Exercise$10.618248,7438,575Dec 03, 2015, 04:22 PM
Hutson Nancy JDirectorNov 30, 2015 Option Exercise$10.618248,74317,466Dec 03, 2015, 04:20 PM
Cohen Fred EDirectorNov 30, 2015 Option Exercise$10.618248,743104,669Dec 03, 2015, 04:19 PM
SANDERS CHARLES ADirectorAug 31, 2015 Option Exercise$11.647518,7427,751Sep 02, 2015, 02:27 PM
Hutson Nancy JDirectorAug 31, 2015 Option Exercise$11.647518,74216,642Sep 02, 2015, 02:24 PM
Cohen Fred EDirectorAug 31, 2015 Option Exercise$11.647518,742103,845Sep 02, 2015, 02:22 PM
STAAB THOMAS R IISenior Vice President and CFOJul 20, 2015 Sale$16.503,50057,750142,644Jul 22, 2015, 05:21 PM
Stonehouse Jon PPresident & CEOJul 15, 2015 Option Exercise$15.6725,526399,992659,211Jul 17, 2015, 09:45 AM
Stonehouse Jon PPresident & CEOJul 15, 2015 Option Exercise$11.8133,868399,981684,737Jul 17, 2015, 09:45 AM
STAAB THOMAS R IISenior Vice President and CFOJun 22, 2015 Option Exercise$4.733,75017,738149,894Jun 24, 2015, 04:57 PM
STAAB THOMAS R IISenior Vice President and CFOJun 22, 2015 Sale$16.003,75060,000146,144Jun 24, 2015, 04:57 PM
Barnes Alane PVP, General Counsel & Corp SecJun 19, 2015 Sale$15.003,00045,00068,876Jun 22, 2015, 04:51 PM
Sheridan William PSenior VP - CMOJun 19, 2015 Option Exercise$1.2070,38984,467165,512Jun 22, 2015, 04:48 PM
Sheridan William PSenior VP - CMOJun 19, 2015 Sale$15.0570,3891,059,35495,123Jun 22, 2015, 04:48 PM
STAAB THOMAS R IISenior Vice President and CFOJun 19, 2015 Option Exercise$3.783,17512,001149,319Jun 22, 2015, 04:38 PM
STAAB THOMAS R IISenior Vice President and CFOJun 18, 2015 Option Exercise$3.786,20023,436155,844Jun 22, 2015, 04:38 PM
STAAB THOMAS R IISenior Vice President and CFOJun 19, 2015 Sale$15.006,675100,125146,144Jun 22, 2015, 04:38 PM
STAAB THOMAS R IISenior Vice President and CFOJun 18, 2015 Sale$13.929,700135,025152,744Jun 22, 2015, 04:38 PM
Stonehouse Jon PPresident & CEOJun 19, 2015 Option Exercise$1.2020,00024,000670,869Jun 22, 2015, 04:34 PM
Stonehouse Jon PPresident & CEOJun 19, 2015 Sale$15.0220,000300,400650,869Jun 22, 2015, 04:34 PM
STAAB THOMAS R IISenior Vice President and CFOJun 05, 2015 Sale$12.756,00076,500153,144Jun 09, 2015, 01:33 PM
STAAB THOMAS R IISenior Vice President and CFOJun 01, 2015 Sale$12.003,00036,000159,144Jun 02, 2015, 02:57 PM
Cohen Fred EDirectorMay 29, 2015 Option Exercise$11.217808,744103,094Jun 01, 2015, 03:53 PM
STAAB THOMAS R IISenior Vice President and CFOMay 18, 2015 Sale$11.003,00033,000162,144May 19, 2015, 04:53 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryMar 19, 2015 Sale$10.1612,105122,987148,697Mar 20, 2015, 04:30 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryMar 05, 2015 Sale$10.5937,400396,066160,802Mar 06, 2015, 02:14 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryMar 04, 2015 Sale$10.5010,495110,198198,202Mar 05, 2015, 02:58 PM
Barnes Alane PVP, General Counsel & Corp SecMar 01, 2015 Option Exercise$10.201,12011,42471,876Mar 03, 2015, 03:59 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryMar 01, 2015 Option Exercise$10.201,63416,667208,697Mar 03, 2015, 03:56 PM
Sheridan William PSenior VP - CMOMar 01, 2015 Option Exercise$10.201,73917,73895,123Mar 03, 2015, 03:54 PM
STAAB THOMAS R IISenior Vice President and CFOMar 01, 2015 Option Exercise$10.204654,743165,144Mar 03, 2015, 03:51 PM
Stonehouse Jon PPresident & CEOMar 01, 2015 Option Exercise$10.205,11852,204650,869Mar 03, 2015, 03:48 PM
Cohen Fred EDirectorFeb 27, 2015 Option Exercise$10.208578,741102,314Mar 03, 2015, 03:45 PM
Hutson Nancy JDirectorFeb 20, 2015 Buy$10.2710,000102,70015,891Feb 23, 2015, 12:50 PM
Barnes Alane PVP, General Counsel & Corp SecJan 20, 2015 Option Exercise$11.172,21024,68672,370Jan 22, 2015, 12:18 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryJan 20, 2015 Option Exercise$11.174,36248,724210,331Jan 22, 2015, 12:16 PM
Sheridan William PSenior VP - CMOJan 20, 2015 Option Exercise$11.175,07456,67795,609Jan 22, 2015, 12:14 PM
STAAB THOMAS R IISenior Vice President and CFOJan 20, 2015 Option Exercise$11.174,47649,997164,913Jan 22, 2015, 12:12 PM
Stonehouse Jon PPresident & CEOJan 20, 2015 Option Exercise$11.1710,608118,491654,280Jan 22, 2015, 12:10 PM
Cohen Fred EDirectorJan 08, 2015 Option Exercise$1.29100,000129,000101,457Jan 09, 2015, 01:19 PM
Barnes Alane PVP, General Counsel & Corp SecJan 01, 2015 Option Exercise$12.162,45329,82874,580Jan 05, 2015, 04:12 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryJan 01, 2015 Option Exercise$12.162,40229,208214,693Jan 05, 2015, 04:10 PM
Sheridan William PSenior VP - CMOJan 01, 2015 Option Exercise$12.162,73533,258100,683Jan 05, 2015, 04:07 PM
STAAB THOMAS R IISenior Vice President and CFOJan 01, 2015 Option Exercise$12.162,45329,828169,389Jan 05, 2015, 04:05 PM
Stonehouse Jon PPresident & CEOJan 01, 2015 Option Exercise$12.165,65268,728664,888Jan 05, 2015, 04:03 PM
Sheridan William PSenior VP - CMODec 30, 2014 Option Exercise$1.4223,10432,808115,622Dec 31, 2014, 02:11 PM
Sheridan William PSenior VP - CMODec 29, 2014 Option Exercise$4.2548,396205,742197,813Dec 31, 2014, 02:11 PM
Sheridan William PSenior VP - CMODec 30, 2014 Sale$12.0623,104278,63492,518Dec 31, 2014, 02:11 PM
Sheridan William PSenior VP - CMODec 29, 2014 Sale$12.43105,2951,308,81792,518Dec 31, 2014, 02:11 PM
STAAB THOMAS R IISenior Vice President and CFODec 29, 2014 Option Exercise$3.789,50035,910172,442Dec 31, 2014, 02:09 PM
STAAB THOMAS R IISenior Vice President and CFODec 29, 2014 Sale$12.569,500119,320162,942Dec 31, 2014, 02:09 PM
Cohen Fred EDirectorNov 28, 2014 Option Exercise$10.818098,7451,457Dec 03, 2014, 03:41 PM
Cohen Fred EDirectorAug 29, 2014 Option Exercise$13.506488,748648Sep 02, 2014, 04:08 PM
STAAB THOMAS R IISenior Vice President and CFOAug 27, 2014 Option Exercise$5.4510,00054,500172,942Aug 29, 2014, 11:04 AM
STAAB THOMAS R IISenior Vice President and CFOAug 27, 2014 Sale$13.5810,000135,800162,942Aug 29, 2014, 11:04 AM
STAAB THOMAS R IISenior Vice President and CFOJul 25, 2014 Option Exercise$11.768,504100,007162,252Jul 28, 2014, 01:21 PM
STAAB THOMAS R IISenior Vice President and CFOJul 25, 2014 Option Exercise$3.7826,455100,000170,756Jul 28, 2014, 01:21 PM
STAAB THOMAS R IISenior Vice President and CFOJul 01, 2014 Option Exercise$4.733,12514,781147,426Jul 02, 2014, 04:33 PM
STAAB THOMAS R IISenior Vice President and CFOJul 01, 2014 Sale$13.003,12540,625144,301Jul 02, 2014, 04:33 PM
STAAB THOMAS R IISenior Vice President and CFOJun 23, 2014 Option Exercise$4.733,12514,781147,426Jun 24, 2014, 03:41 PM
STAAB THOMAS R IISenior Vice President and CFOJun 23, 2014 Sale$12.493,12539,031144,301Jun 24, 2014, 03:41 PM
STAAB THOMAS R IISenior Vice President and CFOJun 17, 2014 Option Exercise$4.733,12514,781147,426Jun 19, 2014, 04:47 PM
STAAB THOMAS R IISenior Vice President and CFOJun 17, 2014 Sale$12.003,12537,500144,301Jun 19, 2014, 04:47 PM
Sheridan William PSenior VP - CMOJun 03, 2014 Option Exercise$9.8610,177100,345148,173Jun 05, 2014, 02:15 PM
Sheridan William PSenior VP - CMOJun 03, 2014 Option Exercise$4.7321,228100,333150,872Jun 05, 2014, 02:15 PM
STAAB THOMAS R IISenior Vice President and CFOMay 22, 2014 Option Exercise$3.7817,68566,849144,301May 27, 2014, 04:03 PM
Stonehouse Jon PPresident & CEOMay 09, 2014 Option Exercise$7.7030,214232,648640,445May 12, 2014, 03:38 PM
Stonehouse Jon PPresident & CEOMay 09, 2014 Option Exercise$5.7640,417232,635659,424May 12, 2014, 03:38 PM
ABERCROMBIE GEORGE BDirectorMar 31, 2014 Option Exercise$1.714,0006,84010,000Apr 01, 2014, 10:37 AM
STAAB THOMAS R IISenior Vice President and CFOMar 14, 2014 Option Exercise$4.733,12514,781129,741Mar 17, 2014, 02:52 PM
STAAB THOMAS R IISenior Vice President and CFOMar 14, 2014 Sale$11.243,12535,125126,616Mar 17, 2014, 02:52 PM
LEE KENNETH B JRDirectorMar 06, 2014 Option Exercise$3.8022,91787,08522,917Mar 07, 2014, 04:17 PM
LEE KENNETH B JRDirectorMar 06, 2014 Sale$12.6912,665160,71910,252Mar 07, 2014, 04:17 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryMar 01, 2014 Option Exercise$11.691,61818,914220,021Mar 07, 2014, 04:14 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryMar 04, 2014 Option Exercise$8.3728,816241,177248,837Mar 07, 2014, 04:14 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryMar 04, 2014 Sale$12.5740,642510,870208,195Mar 07, 2014, 04:14 PM
Barnes Alane PVP, General Counsel & Corp SecMar 01, 2014 Option Exercise$11.691,09012,74281,182Mar 07, 2014, 04:11 PM
Barnes Alane PVP, General Counsel & Corp SecMar 04, 2014 Option Exercise$4.0131,174124,897112,356Mar 07, 2014, 04:11 PM
Barnes Alane PVP, General Counsel & Corp SecMar 04, 2014 Sale$12.6340,734514,47071,622Mar 07, 2014, 04:11 PM
STAAB THOMAS R IISenior Vice President and CFOMar 01, 2014 Option Exercise$11.694615,389126,616Mar 07, 2014, 04:02 PM
STAAB THOMAS R IISenior Vice President and CFOMar 04, 2014 Option Exercise$4.733,00014,190129,616Mar 07, 2014, 04:02 PM
STAAB THOMAS R IISenior Vice President and CFOMar 04, 2014 Sale$12.693,00038,070126,616Mar 07, 2014, 04:02 PM
Stonehouse Jon PPresident & CEOMar 01, 2014 Option Exercise$11.695,11859,829630,242Mar 07, 2014, 03:59 PM
Sheridan William PSenior VP - CMOMar 01, 2014 Option Exercise$11.691,73920,329137,122Mar 07, 2014, 03:56 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryFeb 24, 2014 Option Exercise$12.208,17099,674221,639Feb 25, 2014, 02:34 PM
Babu Yarlagadda SSenior VP - Drug DiscoveryFeb 24, 2014 Option Exercise$4.3023,17999,670229,809Feb 25, 2014, 02:34 PM
Barnes Alane PVP, General Counsel & Corp SecJan 14, 2014 Option Exercise$10.871,49116,20754,487Jan 15, 2014, 08:55 AM
Barnes Alane PVP, General Counsel & Corp SecJan 14, 2014 Option Exercise$1.2013,50016,20055,978Jan 15, 2014, 08:55 AM
STAAB THOMAS R IISenior Vice President and CFOJan 13, 2014 Option Exercise$10.5512,621133,15272,218Jan 15, 2014, 08:51 AM
STAAB THOMAS R IISenior Vice President and CFOJan 13, 2014 Option Exercise$3.7835,225133,15084,839Jan 15, 2014, 08:51 AM
Stonehouse Jon PPresident & CEOJan 01, 2014 Option Exercise$7.608,59265,299504,360Jan 03, 2014, 03:59 PM
STAAB THOMAS R IISenior Vice President and CFOJan 01, 2014 Option Exercise$7.602,45318,64349,614Jan 03, 2014, 03:56 PM
Sheridan William PSR VP - CMOJan 01, 2014 Option Exercise$7.602,73520,78682,539Jan 03, 2014, 03:55 PM
Barnes Alane PVP, General Counsel & Corp SecJan 01, 2014 Option Exercise$7.602,45318,64342,478Jan 03, 2014, 03:52 PM
Babu Yarlagadda SVP Drug DiscoveryJan 01, 2014 Option Exercise$7.602,40218,255152,630Jan 03, 2014, 03:51 PM
ABERCROMBIE GEORGE BDirectorNov 12, 2013 Buy$6.193,00018,5706,000Nov 13, 2013, 04:25 PM
BAKER FELIX10% OwnerAug 01, 2013 Buy$4.401,136,3645,000,0024,832,285Aug 02, 2013, 04:00 PM
Sheridan William PSR VP - CMOMay 28, 2013 Option Exercise$1.2016,40719,68882,274May 29, 2013, 04:00 PM
Stonehouse Jon PPresident & CEOMay 23, 2013 Option Exercise$1.20179,600215,520509,952May 28, 2013, 01:55 PM
Stonehouse Jon PPresident & CEOJan 31, 2013 Option Exercise$1.383,0004,140340,225Mar 14, 2013, 04:34 PM
STAAB THOMAS R IISenior Vice President and CFOJan 31, 2013 Option Exercise$1.382,7453,78852,609Mar 14, 2013, 04:32 PM
Sheridan William PSR VP - CMOJan 31, 2013 Option Exercise$1.383,0004,14067,656Mar 14, 2013, 04:30 PM
ABERCROMBIE GEORGE BDirectorMar 05, 2013 Buy$1.233,0003,6903,000Mar 06, 2013, 04:45 PM
Sheridan William PSR VP - CMOMar 01, 2013 Option Exercise$1.191,7892,12962,867Mar 06, 2013, 04:44 PM
Babu Yarlagadda SVP Drug DiscoveryMar 01, 2013 Option Exercise$1.191,9032,265155,032Mar 06, 2013, 04:42 PM
STAAB THOMAS R IISenior Vice President and CFOMar 01, 2013 Option Exercise$1.1954264549,322Mar 06, 2013, 04:41 PM
Stonehouse Jon PPresident & CEOMar 01, 2013 Option Exercise$1.195,9677,101331,258Mar 06, 2013, 04:38 PM
Jensen PederDirectorDec 14, 2012 Buy$1.5120,00030,20060,000Dec 17, 2012, 12:10 PM
STAAB THOMAS R IISenior Vice President and CFOJul 01, 2012 Option Exercise$3.978,11332,20931,617Jul 02, 2012, 02:49 PM
Jensen PederDirectorJun 05, 2012 Buy$3.1820,00063,68040,000Jun 05, 2012, 07:38 PM
Stonehouse Jon PPresident & CEOMar 15, 2012 Option Exercise$5.2313,61271,191267,719Mar 19, 2012, 04:11 PM
STAAB THOMAS R IISenior Vice President and CFOMar 15, 2012 Option Exercise$5.234,16221,76737,124Mar 19, 2012, 04:07 PM
McCullough DavidVPMar 15, 2012 Option Exercise$5.235,30727,75624,124Mar 19, 2012, 01:12 PM
LOWREY ROBERT SController, PAOMar 15, 2012 Option Exercise$5.232,68614,0489,766Mar 19, 2012, 01:10 PM
Babu Yarlagadda SVP Drug DiscoveryMar 15, 2012 Option Exercise$5.236,87235,941139,935Mar 19, 2012, 12:19 PM
Sheridan William PSR VP - CMOMar 15, 2012 Option Exercise$5.237,54339,45044,656Mar 19, 2012, 11:48 AM
SANDERS CHARLES ADirectorMar 13, 2012 Buy$5.202,00010,4007,000Mar 15, 2012, 03:21 PM
SANDERS CHARLES ADirectorMar 13, 2012 Buy$5.222,00010,4307,000Mar 15, 2012, 12:21 PM
Stonehouse Jon PPresident & CEOMar 02, 2012 Sale$4.782,72113,006239,384Mar 05, 2012, 05:09 PM
Sheridan William PSR VP - CMOMar 02, 2012 Sale$4.789564,57029,330Mar 05, 2012, 03:38 PM
McCullough DavidVPMar 02, 2012 Sale$4.785742,74413,926Mar 05, 2012, 02:58 PM
Babu Yarlagadda SVP Drug DiscoveryMar 02, 2012 Sale$4.788374,001125,769Mar 05, 2012, 02:30 PM
Babu Yarlagadda SVP Drug DiscoveryFeb 22, 2012 Option Exercise$1.1930,91236,78183,650Feb 23, 2012, 04:40 PM
Babu Yarlagadda SVP Drug DiscoveryFeb 22, 2012 Sale$4.2230,912130,44952,738Feb 23, 2012, 04:40 PM
McCullough DavidVPJan 03, 2012 Option Exercise$1.2060,62472,74966,624Jan 05, 2012, 01:47 PM
McCullough DavidVPJan 03, 2012 Sale$2.4560,624148,5296,000Jan 05, 2012, 01:47 PM
McCullough DavidVPDec 07, 2011 Sale$2.854,54212,9456,000Dec 08, 2011, 02:41 PM
Jensen PederDirectorNov 18, 2011 Buy$2.7510,00027,50020,000Nov 18, 2011, 02:52 PM
Stonehouse Jon PPresident & CEOAug 08, 2011 Buy$2.5210,00025,190217,492Aug 09, 2011, 01:55 PM
Jensen PederDirectorMay 12, 2011 Buy$3.5610,00035,60010,000May 16, 2011, 06:01 PM
Grant StuartSR VP & CFOMar 16, 2011 Option Exercise$1.2065,00078,00063,102Mar 18, 2011, 04:49 PM
Grant StuartSR VP & CFOMar 16, 2011 Sale$3.3922,61576,72557,102Mar 18, 2011, 04:49 PM
Stonehouse Jon PPresident & CEOMar 18, 2011 Buy$3.4010,00033,988194,180Mar 18, 2011, 04:25 PM
Grant StuartSR VP & CFOAug 04, 2010 Option Exercise$1.202,5003,00014,217Aug 06, 2010, 12:42 PM
Grant StuartSR VP & CFOAug 04, 2010 Sale$6.202,50015,50011,717Aug 06, 2010, 12:42 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
MILANO VINCENTDirector02/29/20245,624
HEGGIE THERESADirector02/29/20245,624
Thackray Helen M.Chief R&D Officer12/19/202333,759
Stonehouse Jon PPresident & CEO12/19/202385,238
Gayer Charles KChief Commercial Officer12/19/202315,016
Doyle AnthonyChief Financial Officer12/19/202315,016
Barnes Alane PChief Legal Officer12/19/202315,016
Thackray Helen M.Chief R&D Officer12/14/202319,489
Stonehouse Jon PPresident & CEO12/14/202387,397
Gayer Charles KChief Commercial Officer12/14/202337,551
Doyle AnthonyChief Financial Officer12/14/202335,204
Barnes Alane PChief Legal Officer12/14/202325,816
MILANO VINCENTDirector11/30/20235,621
HEGGIE THERESADirector11/30/20235,621
MILANO VINCENTDirector08/31/20235,624
HEGGIE THERESADirector08/31/20235,624
SANDERS MACHELLEDirector06/15/202331,920
Hutson Nancy JDirector06/14/2023103,443
MILANO VINCENTDirector05/31/20235,624
LEVIN ALAN GDirector05/31/202311,247
HEGGIE THERESADirector05/31/20235,624
Thackray Helen M.Chief R&D Officer04/03/202358,030
Stonehouse Jon PPresident & CEO03/21/202399,997
MILANO VINCENTDirector02/28/20235,620
INGRAM ROBERT ALEXANDERDirector02/28/202319,992
Stonehouse Jon PPresident & CEO02/01/2023545,000
Stonehouse Jon PPresident & CEO02/01/20231,038,000
LEE KENNETH B JRDirector01/31/202325,650
Stonehouse Jon PPresident & CEO12/15/2022153,690
Thackray Helen M.Chief R&D Officer12/15/202234,031
Doyle AnthonyChief Financial Officer12/15/202262,130
Gayer Charles KChief Commercial Officer12/15/202266,490
Jones Michael LExec. Director, Finance - PAO12/15/20224,850
Barnes Alane PChief Legal Officer12/15/202245,424
Jones Michael LExec. Director, Finance - PAO12/01/202212,212
Jones Michael LExec. Director, Finance - PAO12/01/2022111,886
Stonehouse Jon PPresident & CEO12/01/2022305,182
Stonehouse Jon PPresident & CEO12/02/2022117,372
Stonehouse Jon PPresident & CEO12/02/20221,057,997
Stonehouse Jon PPresident & CEO12/01/20222,793,921
HEGGIE THERESADirector11/30/20225,625
MILANO VINCENTDirector11/30/20225,625
LEVIN ALAN GDirector11/30/202211,249
INGRAM ROBERT ALEXANDERDirector11/30/202220,000
Babu Yarlagadda SChief Discovery Officer11/14/2022142,000
Babu Yarlagadda SChief Discovery Officer11/14/2022437,428
MILANO VINCENTDirector08/31/20225,616
LEVIN ALAN GDirector08/31/202211,245
INGRAM ROBERT ALEXANDERDirector08/31/202219,988
HEGGIE THERESADirector08/31/20225,616
ASELAGE STEVEDirector05/31/20225,297
HEGGIE THERESADirector05/31/202210,595
LEVIN ALAN GDirector05/31/202210,595
INGRAM ROBERT ALEXANDERDirector05/31/202219,346
ABERCROMBIE GEORGE BDirector04/18/202216,600
ABERCROMBIE GEORGE BDirector04/18/202255,200
Thackray Helen M.Chief R&D Officer04/01/2022123,120
Sheridan William PChief Medical Officer03/10/2022477,532
Sheridan William PChief Medical Officer03/10/20222,719,493
Babu Yarlagadda SChief Discovery Officer03/07/2022343,200
Jones Michael LExec. Director, Finance - PAO03/01/202210,879
Jones Michael LExec. Director, Finance - PAO03/01/202239,560
LEVIN ALAN GDirector02/28/20229,999
INGRAM ROBERT ALEXANDERDirector02/28/202218,736
ABERCROMBIE GEORGE BDirector02/15/202216,600
ABERCROMBIE GEORGE BDirector02/15/202292,500
Stonehouse Jon PPresident & CEO01/11/2022870,320
Stonehouse Jon PPresident & CEO01/11/20222,767,360
Babu Yarlagadda SChief Discovery Officer12/07/2021293,260
Babu Yarlagadda SChief Discovery Officer12/07/2021367,220
ASELAGE STEVEDirector11/30/20214,993
LEVIN ALAN GDirector11/30/20219,998
HEGGIE THERESADirector11/30/20219,998
INGRAM ROBERT ALEXANDERDirector11/30/202118,741
MILANO VINCENTDirector11/24/202191,425
Doyle AnthonyChief Financial Officer11/23/2021440,020
ABERCROMBIE GEORGE BDirector11/15/202116,600
ABERCROMBIE GEORGE BDirector11/15/202161,350
Hutson Nancy JDirector10/15/2021363,450
Hutson Nancy JDirector10/15/20211,617,000
ABERCROMBIE GEORGE BDirector09/15/202113,150
ABERCROMBIE GEORGE BDirector09/15/202175,300
LEE KENNETH B JRDirector09/13/202148,300
LEE KENNETH B JRDirector09/13/202192,100
ABERCROMBIE GEORGE BDirector09/10/2021202,710
ABERCROMBIE GEORGE BDirector09/10/20211,116,660
LEVIN ALAN GDirector08/31/20219,998
INGRAM ROBERT ALEXANDERDirector08/31/202118,738
HEGGIE THERESADirector08/31/20219,998
ASELAGE STEVEDirector08/31/20214,999
ABERCROMBIE GEORGE BDirector07/15/202113,150
ABERCROMBIE GEORGE BDirector07/15/202178,450
Hutson Nancy JDirector05/28/20214,999
ASELAGE STEVEDirector05/28/20219,998
Barnes Alane PChief Legal Officer05/11/2021425,442
Barnes Alane PChief Legal Officer05/12/2021169,580
Barnes Alane PChief Legal Officer05/11/20211,237,471
ABERCROMBIE GEORGE BDirector05/10/202188,900
Jones Michael LExec. Director, Finance - PAO03/18/202115,795
INGRAM ROBERT ALEXANDERDirector02/26/202118,746
Hutson Nancy JDirector02/26/20214,991
HEGGIE THERESADirector02/26/20214,991
ASELAGE STEVEDirector02/26/20219,993
Sheridan William PSenior VP - CMO02/22/2021171,188
Sheridan William PSenior VP - CMO02/22/2021477,262
Babu Yarlagadda SSenior VP - Drug Discovery02/19/2021258,629
Babu Yarlagadda SSenior VP - Drug Discovery02/19/2021207,500
Stonehouse Jon PPresident & CEO12/15/2020557,254
Stonehouse Jon PPresident & CEO12/15/20201,117,193
Barnes Alane PSenior VP, Chief Legal Officer12/11/202057,025
Barnes Alane PSenior VP, Chief Legal Officer12/11/2020109,378
Barnes Alane PSenior VP, Chief Legal Officer12/04/202057,025
Barnes Alane PSenior VP, Chief Legal Officer12/04/202085,606
HEGGIE THERESADirector11/30/20204,998
ASELAGE STEVEDirector11/30/20209,995
Hutson Nancy JDirector11/30/20204,998
INGRAM ROBERT ALEXANDERDirector11/30/202018,749
Hutson Nancy JDirector08/31/20204,997
HEGGIE THERESADirector08/31/20204,997
ASELAGE STEVEDirector08/31/20209,997
INGRAM ROBERT ALEXANDERDirector08/31/202018,750
Doyle AnthonyChief Financial Officer08/11/2020220,320
ASELAGE STEVEDirector06/01/20204,998
HEGGIE THERESADirector06/01/20204,998
Hutson Nancy JDirector06/01/20209,997
INGRAM ROBERT ALEXANDERDirector06/01/202018,749
Hutson Nancy JDirector03/01/20209,999
INGRAM ROBERT ALEXANDERDirector03/01/202018,750
HEGGIE THERESADirector03/01/20204,998
ASELAGE STEVEDirector03/01/20204,998
HEGGIE THERESADirector12/01/20194,999
ASELAGE STEVEDirector12/01/20194,999
Hutson Nancy JDirector12/01/20199,998
INGRAM ROBERT ALEXANDERDirector12/01/201918,747
Stonehouse Jon PPresident & CEO11/18/201972,500
Sniecinski MeganChief Business Officer11/18/201965,250
LEE KENNETH B JRDirector11/18/20197,250
INGRAM ROBERT ALEXANDERDirector11/18/201929,000
Hutson Nancy JDirector11/18/201914,500
HEGGIE THERESADirector11/18/20197,250
Barnes Alane PSenior VP, Chief Legal Officer11/18/201929,000
Babu Yarlagadda SSenior VP - Drug Discovery11/18/201936,250
ASELAGE STEVEDirector11/18/201921,750
HEGGIE THERESADirector09/01/20194,999
ASELAGE STEVEDirector09/01/20194,999
Hutson Nancy JDirector09/01/20199,999
INGRAM ROBERT ALEXANDERDirector09/01/201918,747
ASELAGE STEVEDirector05/22/201910,710
STAAB THOMAS R IISenior Vice President and CFO05/16/20196,745
STAAB THOMAS R IISenior Vice President and CFO05/17/201918,625
STAAB THOMAS R IISenior Vice President and CFO05/16/201955,970
STAAB THOMAS R IISenior Vice President and CFO05/15/20196,745
STAAB THOMAS R IISenior Vice President and CFO05/14/20196,390
STAAB THOMAS R IISenior Vice President and CFO05/15/201957,420
STAAB THOMAS R IISenior Vice President and CFO05/14/201934,290
STAAB THOMAS R IISenior Vice President and CFO05/13/201953,723
STAAB THOMAS R IISenior Vice President and CFO05/09/201953,723
STAAB THOMAS R IISenior Vice President and CFO05/13/201975,660
STAAB THOMAS R IISenior Vice President and CFO05/09/201974,393
STAAB THOMAS R IISenior Vice President and CFO05/02/201942,703
STAAB THOMAS R IISenior Vice President and CFO05/06/201949,590
STAAB THOMAS R IISenior Vice President and CFO05/06/201969,750
STAAB THOMAS R IISenior Vice President and CFO05/02/201956,575
STAAB THOMAS R IISenior Vice President and CFO04/04/201941,325
STAAB THOMAS R IISenior Vice President and CFO04/04/201966,075
ASELAGE STEVEDirector03/12/201916,600
Babu Yarlagadda SSenior VP - Drug Discovery01/31/201981,479
Babu Yarlagadda SSenior VP - Drug Discovery01/31/201938,249
STAAB THOMAS R IISenior Vice President and CFO01/28/201927,250
STAAB THOMAS R IISenior Vice President and CFO01/28/201949,250
Powell LynneSenior VP - CCO01/28/201919,320
Powell LynneSenior VP - CCO01/25/201919,320
Powell LynneSenior VP - CCO01/28/201959,340
Powell LynneSenior VP - CCO01/25/201957,600
Powell LynneSenior VP - CCO01/18/20196,440
Powell LynneSenior VP - CCO01/18/201918,800
Powell LynneSenior VP - CCO01/16/20199,808
Powell LynneSenior VP - CCO01/16/201928,236
Powell LynneSenior VP - CCO01/14/20193,072
Powell LynneSenior VP - CCO01/14/20198,777
STAAB THOMAS R IISenior Vice President and CFO01/01/20196,335
Barnes Alane PSenior VP, Chief Legal Officer01/01/20193,414
Sheridan William PSenior VP - CMO01/01/20198,772
Stonehouse Jon PPresident & CEO01/01/201928,794
Babu Yarlagadda SSenior VP - Drug Discovery01/01/20196,222
Sheridan William PSenior VP - CMO12/18/2018155,299
Powell LynneSenior VP - CCO12/10/201812,880
Powell LynneSenior VP - CCO12/10/201836,240
Stonehouse Jon PPresident & CEO12/03/201896,000
Stonehouse Jon PPresident & CEO12/03/2018729,600
STAAB THOMAS R IISenior Vice President and CFO12/04/201837,063
Barnes Alane PSenior VP, Chief Legal Officer11/30/201835,500
Barnes Alane PSenior VP, Chief Legal Officer11/30/2018401,710
Erck Stanley CDirector11/28/201812,416
Powell LynneSenior VP - CCO11/21/201838,640
Powell LynneSenior VP - CCO11/21/2018130,840
STAAB THOMAS R IISenior Vice President and CFO11/23/201813,230
STAAB THOMAS R IISenior Vice President and CFO11/21/201853,710
STAAB THOMAS R IISenior Vice President and CFO11/23/201833,810
STAAB THOMAS R IISenior Vice President and CFO11/21/2018110,610
Powell LynneSenior VP - CCO11/20/201829,389
Powell LynneSenior VP - CCO11/19/2018621
Powell LynneSenior VP - CCO11/20/2018130,714
Powell LynneSenior VP - CCO11/19/20181,602
STAAB THOMAS R IISenior Vice President and CFO11/19/2018283
STAAB THOMAS R IISenior Vice President and CFO11/20/201838,405
STAAB THOMAS R IISenior Vice President and CFO11/20/201896,494
STAAB THOMAS R IISenior Vice President and CFO11/19/2018623
STAAB THOMAS R IISenior Vice President and CFO11/08/201844,485
STAAB THOMAS R IISenior Vice President and CFO11/07/20182,164
STAAB THOMAS R IISenior Vice President and CFO11/08/2018109,011
STAAB THOMAS R IISenior Vice President and CFO11/07/20185,376
Powell LynneSenior VP - CCO11/08/201817,002
Powell LynneSenior VP - CCO11/07/2018966
Powell LynneSenior VP - CCO11/07/20182,400
Powell LynneSenior VP - CCO11/08/201843,032
Powell LynneSenior VP - CCO11/05/2018322
Powell LynneSenior VP - CCO11/05/2018800
STAAB THOMAS R IISenior Vice President and CFO11/05/2018692
STAAB THOMAS R IISenior Vice President and CFO11/05/20181,720
Powell LynneSenior VP - CCO11/02/20183,220
Powell LynneSenior VP - CCO11/02/20188,000
STAAB THOMAS R IISenior Vice President and CFO11/02/201836,916
STAAB THOMAS R IISenior Vice President and CFO11/02/201885,090
Powell LynneSenior VP - CCO11/01/201811,595
STAAB THOMAS R IISenior Vice President and CFO10/19/201811,907
STAAB THOMAS R IISenior Vice President and CFO10/19/201823,467
Powell LynneSenior VP - CCO10/19/2018750
STAAB THOMAS R IISenior Vice President and CFO10/03/20183,508
STAAB THOMAS R IISenior Vice President and CFO10/02/201830,085
STAAB THOMAS R IISenior Vice President and CFO10/03/20187,802
STAAB THOMAS R IISenior Vice President and CFO10/02/201863,556
Sheridan William PSenior VP - CMO08/09/201888,750
Sheridan William PSenior VP - CMO08/09/2018439,375
Sheridan William PSenior VP - CMO06/01/2018108,649
Sheridan William PSenior VP - CMO06/01/2018265,306
INGRAM ROBERT ALEXANDERDirector06/01/201818,750
Hutson Nancy JDirector06/01/20189,999
Stonehouse Jon PPresident & CEO05/17/2018100,006
Barnes Alane PVP, General Counsel & Corp Sec05/15/201817,754
Barnes Alane PVP, General Counsel & Corp Sec05/15/201817,750
Babu Yarlagadda SSenior VP - Drug Discovery03/06/2018109,427
Babu Yarlagadda SSenior VP - Drug Discovery03/06/201897,800
Stonehouse Jon PPresident & CEO02/28/2018214,823
Stonehouse Jon PPresident & CEO02/28/2018185,654
Barnes Alane PVP, General Counsel & Corp Sec02/28/201821,871
INGRAM ROBERT ALEXANDERDirector03/01/201818,747
Hutson Nancy JDirector03/01/201810,000
Barnes Alane PVP, General Counsel & Corp Sec01/20/201810,962
Babu Yarlagadda SSenior VP - Drug Discovery01/20/201821,644
Sheridan William PSenior VP - CMO01/20/201825,871
STAAB THOMAS R IISenior Vice President and CFO01/20/201822,243
Stonehouse Jon PPresident & CEO01/20/201853,575
Barnes Alane PVP, General Counsel & Corp Sec01/01/20182,254
Babu Yarlagadda SSenior VP - Drug Discovery01/01/20184,115
Sheridan William PSenior VP - CMO01/01/20185,740
STAAB THOMAS R IISenior Vice President and CFO01/01/20184,183
Stonehouse Jon PPresident & CEO01/01/201813,336
INGRAM ROBERT ALEXANDERDirector12/01/201718,745
Hutson Nancy JDirector12/01/20179,997
Sheridan William PSenior VP - CMO11/13/2017303,543
Cohen Fred EDirector09/18/2017231,647
Cohen Fred EDirector09/18/2017294,035
INGRAM ROBERT ALEXANDERDirector09/01/201718,748
Hutson Nancy JDirector09/01/20179,996
INGRAM ROBERT ALEXANDERDirector06/01/20179,996
Hutson Nancy JDirector06/01/20179,996
Cohen Fred EDirector06/01/20179,996
STAAB THOMAS R IISenior Vice President and CFO05/22/201736,659
STAAB THOMAS R IISenior Vice President and CFO05/22/201736,658
STAAB THOMAS R IISenior Vice President and CFO03/20/201712,285
STAAB THOMAS R IISenior Vice President and CFO03/20/201729,900
STAAB THOMAS R IISenior Vice President and CFO03/16/2017108,310
STAAB THOMAS R IISenior Vice President and CFO03/16/2017108,300
STAAB THOMAS R IISenior Vice President and CFO03/10/201712,285
STAAB THOMAS R IISenior Vice President and CFO03/10/201729,445
STAAB THOMAS R IISenior Vice President and CFO03/08/201724,570
STAAB THOMAS R IISenior Vice President and CFO03/08/201754,762
STAAB THOMAS R IISenior Vice President and CFO03/06/201712,285
STAAB THOMAS R IISenior Vice President and CFO03/06/201725,675
INGRAM ROBERT ALEXANDERDirector03/02/20179,996
Hutson Nancy JDirector03/01/20179,996
Cohen Fred EDirector03/01/20179,996
Barnes Alane PVP, General Counsel & Corp Sec01/20/201715,464
Babu Yarlagadda SSenior VP - Drug Discovery01/20/201730,244
Sheridan William PSenior VP - CMO01/20/201734,278
STAAB THOMAS R IISenior Vice President and CFO01/20/201730,928
Stonehouse Jon PPresident & CEO01/20/201762,903
Barnes Alane PVP, General Counsel & Corp Sec01/01/20178,109
Babu Yarlagadda SSenior VP - Drug Discovery01/01/201710,375
Sheridan William PSenior VP - CMO01/01/201713,173
STAAB THOMAS R IISenior Vice President and CFO01/01/201710,609
Stonehouse Jon PPresident & CEO01/01/201754,406
STAAB THOMAS R IISenior Vice President and CFO12/19/201612,285
STAAB THOMAS R IISenior Vice President and CFO12/19/201624,212
INGRAM ROBERT ALEXANDERDirector12/01/20169,995
Hutson Nancy JDirector12/01/20169,995
Cohen Fred EDirector12/01/20169,995
Barnes Alane PVP, General Counsel & Corp Sec09/14/201635,684
INGRAM ROBERT ALEXANDERDirector09/01/201610,000
Hutson Nancy JDirector09/01/201610,000
Cohen Fred EDirector09/01/201610,000
Babu Yarlagadda SSenior VP - Drug Discovery08/25/2016121,800
BAKER BROS. ADVISORS LP10% Owner08/15/20161,931,040
BAKER BROS. ADVISORS LP10% Owner08/12/201618,315,817
BAKER BROS. ADVISORS LP10% Owner08/16/20164,246
STAAB THOMAS R IISenior Vice President and CFO08/12/201623,793
STAAB THOMAS R IISenior Vice President and CFO08/11/20166,595
STAAB THOMAS R IISenior Vice President and CFO08/09/201664,576
Hutson Nancy JDirector05/31/20168,750
Cohen Fred EDirector05/31/20168,750
Barnes Alane PVP, General Counsel & Corp Sec03/01/20161,463
Babu Yarlagadda SSenior VP - Drug Discovery03/01/20161,930
Sheridan William PSenior VP - CMO03/01/20161,702
STAAB THOMAS R IISenior Vice President and CFO03/01/2016990
Stonehouse Jon PPresident & CEO03/01/20165,881
SANDERS CHARLES ADirector02/29/20168,748
Hutson Nancy JDirector02/29/20168,748
Cohen Fred EDirector02/29/20168,748
BAKER BROS. ADVISORS LP10% Owner02/05/2016284,656
BAKER BROS. ADVISORS LP10% Owner02/04/2016164,915
BAKER BROS. ADVISORS LP10% Owner02/03/2016573,311
BAKER BROS. ADVISORS LP10% Owner02/02/2016598,360
Barnes Alane PVP, General Counsel & Corp Sec01/29/201627,503
BAKER BROS. ADVISORS LP10% Owner01/28/2016172,015
BAKER BROS. ADVISORS LP10% Owner01/27/2016441,971
Powell LynneSenior VP - CCO01/26/201628,066
BAKER BROS. ADVISORS LP10% Owner01/22/201622,389
BAKER BROS. ADVISORS LP10% Owner01/21/2016755,368
Barnes Alane PVP, General Counsel & Corp Sec01/20/201619,622
Babu Yarlagadda SSenior VP - Drug Discovery01/20/201635,666
Sheridan William PSenior VP - CMO01/20/201640,460
STAAB THOMAS R IISenior Vice President and CFO01/20/201636,414
Stonehouse Jon PPresident & CEO01/20/201680,211
Stonehouse Jon PPresident & CEO01/20/201699,998
STAAB THOMAS R IISenior Vice President and CFO01/19/201627,200
BAKER BROS. ADVISORS LP10% Owner01/20/2016362,171
BAKER BROS. ADVISORS LP10% Owner01/19/2016656,750
BAKER BROS. ADVISORS LP10% Owner01/15/20161,491,222
Barnes Alane PVP, General Counsel & Corp Sec01/01/201613,220
Babu Yarlagadda SSenior VP - Drug Discovery01/01/201616,914
Sheridan William PSenior VP - CMO01/01/201621,476
STAAB THOMAS R IISenior Vice President and CFO01/01/201617,296
Stonehouse Jon PPresident & CEO01/01/201683,499
STAAB THOMAS R IISenior Vice President and CFO12/21/201533,145
STAAB THOMAS R IISenior Vice President and CFO12/17/201531,470
SANDERS CHARLES ADirector11/30/20158,743
Hutson Nancy JDirector11/30/20158,743
Cohen Fred EDirector11/30/20158,743
SANDERS CHARLES ADirector08/31/20158,742
Hutson Nancy JDirector08/31/20158,742
Cohen Fred EDirector08/31/20158,742
STAAB THOMAS R IISenior Vice President and CFO07/20/201557,750
Stonehouse Jon PPresident & CEO07/15/2015399,992
Stonehouse Jon PPresident & CEO07/15/2015399,981
STAAB THOMAS R IISenior Vice President and CFO06/22/201517,738
STAAB THOMAS R IISenior Vice President and CFO06/22/201560,000
Barnes Alane PVP, General Counsel & Corp Sec06/19/201545,000
Sheridan William PSenior VP - CMO06/19/201584,467
Sheridan William PSenior VP - CMO06/19/20151,059,354
STAAB THOMAS R IISenior Vice President and CFO06/19/201512,001
STAAB THOMAS R IISenior Vice President and CFO06/18/201523,436
STAAB THOMAS R IISenior Vice President and CFO06/19/2015100,125
STAAB THOMAS R IISenior Vice President and CFO06/18/2015135,025
Stonehouse Jon PPresident & CEO06/19/201524,000
Stonehouse Jon PPresident & CEO06/19/2015300,400
STAAB THOMAS R IISenior Vice President and CFO06/05/201576,500
STAAB THOMAS R IISenior Vice President and CFO06/01/201536,000
Cohen Fred EDirector05/29/20158,744
STAAB THOMAS R IISenior Vice President and CFO05/18/201533,000
Babu Yarlagadda SSenior VP - Drug Discovery03/19/2015122,987
Babu Yarlagadda SSenior VP - Drug Discovery03/05/2015396,066
Babu Yarlagadda SSenior VP - Drug Discovery03/04/2015110,198
Barnes Alane PVP, General Counsel & Corp Sec03/01/201511,424
Babu Yarlagadda SSenior VP - Drug Discovery03/01/201516,667
Sheridan William PSenior VP - CMO03/01/201517,738
STAAB THOMAS R IISenior Vice President and CFO03/01/20154,743
Stonehouse Jon PPresident & CEO03/01/201552,204
Cohen Fred EDirector02/27/20158,741
Hutson Nancy JDirector02/20/2015102,700
Barnes Alane PVP, General Counsel & Corp Sec01/20/201524,686
Babu Yarlagadda SSenior VP - Drug Discovery01/20/201548,724
Sheridan William PSenior VP - CMO01/20/201556,677
STAAB THOMAS R IISenior Vice President and CFO01/20/201549,997
Stonehouse Jon PPresident & CEO01/20/2015118,491
Cohen Fred EDirector01/08/2015129,000
Barnes Alane PVP, General Counsel & Corp Sec01/01/201529,828
Babu Yarlagadda SSenior VP - Drug Discovery01/01/201529,208
Sheridan William PSenior VP - CMO01/01/201533,258
STAAB THOMAS R IISenior Vice President and CFO01/01/201529,828
Stonehouse Jon PPresident & CEO01/01/201568,728
Sheridan William PSenior VP - CMO12/30/201432,808
Sheridan William PSenior VP - CMO12/29/2014205,742
Sheridan William PSenior VP - CMO12/30/2014278,634
Sheridan William PSenior VP - CMO12/29/20141,308,817
STAAB THOMAS R IISenior Vice President and CFO12/29/201435,910
STAAB THOMAS R IISenior Vice President and CFO12/29/2014119,320
Cohen Fred EDirector11/28/20148,745
Cohen Fred EDirector08/29/20148,748
STAAB THOMAS R IISenior Vice President and CFO08/27/201454,500
STAAB THOMAS R IISenior Vice President and CFO08/27/2014135,800
STAAB THOMAS R IISenior Vice President and CFO07/25/2014100,007
STAAB THOMAS R IISenior Vice President and CFO07/25/2014100,000
STAAB THOMAS R IISenior Vice President and CFO07/01/201414,781
STAAB THOMAS R IISenior Vice President and CFO07/01/201440,625
STAAB THOMAS R IISenior Vice President and CFO06/23/201414,781
STAAB THOMAS R IISenior Vice President and CFO06/23/201439,031
STAAB THOMAS R IISenior Vice President and CFO06/17/201414,781
STAAB THOMAS R IISenior Vice President and CFO06/17/201437,500
Sheridan William PSenior VP - CMO06/03/2014100,345
Sheridan William PSenior VP - CMO06/03/2014100,333
STAAB THOMAS R IISenior Vice President and CFO05/22/201466,849
Stonehouse Jon PPresident & CEO05/09/2014232,648
Stonehouse Jon PPresident & CEO05/09/2014232,635
ABERCROMBIE GEORGE BDirector03/31/20146,840
STAAB THOMAS R IISenior Vice President and CFO03/14/201414,781
STAAB THOMAS R IISenior Vice President and CFO03/14/201435,125
LEE KENNETH B JRDirector03/06/201487,085
LEE KENNETH B JRDirector03/06/2014160,719
Babu Yarlagadda SSenior VP - Drug Discovery03/01/201418,914
Babu Yarlagadda SSenior VP - Drug Discovery03/04/2014241,177
Babu Yarlagadda SSenior VP - Drug Discovery03/04/2014510,870
Barnes Alane PVP, General Counsel & Corp Sec03/01/201412,742
Barnes Alane PVP, General Counsel & Corp Sec03/04/2014124,897
Barnes Alane PVP, General Counsel & Corp Sec03/04/2014514,470
STAAB THOMAS R IISenior Vice President and CFO03/01/20145,389
STAAB THOMAS R IISenior Vice President and CFO03/04/201414,190
STAAB THOMAS R IISenior Vice President and CFO03/04/201438,070
Stonehouse Jon PPresident & CEO03/01/201459,829
Sheridan William PSenior VP - CMO03/01/201420,329
Babu Yarlagadda SSenior VP - Drug Discovery02/24/201499,674
Babu Yarlagadda SSenior VP - Drug Discovery02/24/201499,670
Barnes Alane PVP, General Counsel & Corp Sec01/14/201416,207
Barnes Alane PVP, General Counsel & Corp Sec01/14/201416,200
STAAB THOMAS R IISenior Vice President and CFO01/13/2014133,152
STAAB THOMAS R IISenior Vice President and CFO01/13/2014133,150
Stonehouse Jon PPresident & CEO01/01/201465,299
STAAB THOMAS R IISenior Vice President and CFO01/01/201418,643
Sheridan William PSR VP - CMO01/01/201420,786
Barnes Alane PVP, General Counsel & Corp Sec01/01/201418,643
Babu Yarlagadda SVP Drug Discovery01/01/201418,255
ABERCROMBIE GEORGE BDirector11/12/201318,570
BAKER FELIX10% Owner08/01/20135,000,002
Sheridan William PSR VP - CMO05/28/201319,688
Stonehouse Jon PPresident & CEO05/23/2013215,520
Stonehouse Jon PPresident & CEO01/31/20134,140
STAAB THOMAS R IISenior Vice President and CFO01/31/20133,788
Sheridan William PSR VP - CMO01/31/20134,140
ABERCROMBIE GEORGE BDirector03/05/20133,690
Sheridan William PSR VP - CMO03/01/20132,129
Babu Yarlagadda SVP Drug Discovery03/01/20132,265
STAAB THOMAS R IISenior Vice President and CFO03/01/2013645
Stonehouse Jon PPresident & CEO03/01/20137,101
Jensen PederDirector12/14/201230,200
STAAB THOMAS R IISenior Vice President and CFO07/01/201232,209
Jensen PederDirector06/05/201263,680
Stonehouse Jon PPresident & CEO03/15/201271,191
STAAB THOMAS R IISenior Vice President and CFO03/15/201221,767
McCullough DavidVP03/15/201227,756
LOWREY ROBERT SController, PAO03/15/201214,048
Babu Yarlagadda SVP Drug Discovery03/15/201235,941
Sheridan William PSR VP - CMO03/15/201239,450
SANDERS CHARLES ADirector03/13/201210,400
SANDERS CHARLES ADirector03/13/201210,430
Stonehouse Jon PPresident & CEO03/02/201213,006
Sheridan William PSR VP - CMO03/02/20124,570
McCullough DavidVP03/02/20122,744
Babu Yarlagadda SVP Drug Discovery03/02/20124,001
Babu Yarlagadda SVP Drug Discovery02/22/201236,781
Babu Yarlagadda SVP Drug Discovery02/22/2012130,449
McCullough DavidVP01/03/201272,749
McCullough DavidVP01/03/2012148,529
McCullough DavidVP12/07/201112,945
Jensen PederDirector11/18/201127,500
Stonehouse Jon PPresident & CEO08/08/201125,190
Jensen PederDirector05/12/201135,600
Grant StuartSR VP & CFO03/16/201178,000
Grant StuartSR VP & CFO03/16/201176,725
Stonehouse Jon PPresident & CEO03/18/201133,988
Grant StuartSR VP & CFO08/04/20103,000
Grant StuartSR VP & CFO08/04/201015,500
Load More Insider Transactions
FUNDS WITH A POSITION IN BIOCRYST PHARMACEUTICALS INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.18,681,3700.00285%11.37%Other
BAKER BROS. ADVISORS LP10,126,1760.69%-20.33%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)4,539,5250.5%38.15%Other
FISHER ASSET MANAGEMENT, LLC2,884,5690.00914%-9.44%Other
GEODE CAPITAL MANAGEMENT, LLC4,260,6380.00267%8.94%Other
BALYASNY ASSET MANAGEMENT L.P.1,971,5860.02%382.88%Event Driven
RENAISSANCE TECHNOLOGIES LLC1,754,9800.02%769.47%Other
AQR CAPITAL MANAGEMENT LLC373,9440.00422%408.65%Other
UBS OCONNOR LLC60,1590.03%-75.12%Value
TUDOR INVESTMENT CORP ET AL209,9050.01%122.27%Event Driven, Other
ALPS ADVISORS INC138,1010.0065%-1.25%Other
GOTHAM ASSET MANAGEMENT, LLC69,0330.01%ExitedOther
D. E. SHAW & CO., INC.30,6310.00016%NewOther
CHANGE IN SHARES OUTSTANDING FOR BIOCRYST PHARMACEUTICALS INC.
STOCK BUYBACKS FOR BIOCRYST PHARMACEUTICALS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
6.26%
1Q
12/31/2023
06/30/2023
6.55%
2Q
12/31/2023
03/31/2023
6.90%
3Q
12/31/2023
12/31/2022
7.80%
4Q
12/31/2023
09/30/2022
8.23%
5Q
12/31/2023
06/30/2022
8.57%
6Q
12/31/2023
03/31/2022
8.98%
7Q
12/31/2023
12/31/2021
10.80%
8Q
12/31/2023
09/30/2021
12.51%
9Q
12/31/2023
06/30/2021
13.13%
10Q
12/31/2023
03/31/2021
13.63%
11Q
12/31/2023
12/31/2020
14.05%
12Q
12/31/2023
09/30/2020
14.15%
13Q
12/31/2023
06/30/2020
24.72%
14Q
12/31/2023
03/31/2020
30.72%
15Q
12/31/2023
12/31/2019
53.27%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
6.26%
1Q
06/30/2023
6.55%
2Q
03/31/2023
6.90%
3Q
12/31/2022
7.80%
4Q
09/30/2022
8.23%
5Q
06/30/2022
8.57%
6Q
03/31/2022
8.98%
7Q
12/31/2021
10.80%
8Q
09/30/2021
12.51%
9Q
06/30/2021
13.13%
10Q
03/31/2021
13.63%
11Q
12/31/2020
14.05%
12Q
09/30/2020
14.15%
13Q
06/30/2020
24.72%
14Q
03/31/2020
30.72%
15Q
12/31/2019
53.27%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BIOCRYST PHARMACEUTICALS INC.
LOADING...